CA3016789A1 - Organic molecules, in particular for use in optoelectronic devices - Google Patents
Organic molecules, in particular for use in optoelectronic devices Download PDFInfo
- Publication number
- CA3016789A1 CA3016789A1 CA3016789A CA3016789A CA3016789A1 CA 3016789 A1 CA3016789 A1 CA 3016789A1 CA 3016789 A CA3016789 A CA 3016789A CA 3016789 A CA3016789 A CA 3016789A CA 3016789 A1 CA3016789 A1 CA 3016789A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- optionally substituted
- organic
- independently
- substituents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000005693 optoelectronics Effects 0.000 title claims abstract description 21
- 125000001424 substituent group Chemical group 0.000 claims abstract description 53
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims abstract description 26
- 229910052805 deuterium Inorganic materials 0.000 claims abstract description 26
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 16
- 239000001257 hydrogen Substances 0.000 claims abstract description 16
- 150000002894 organic compounds Chemical class 0.000 claims abstract 3
- 125000006749 (C6-C60) aryl group Chemical group 0.000 claims abstract 2
- 239000000463 material Substances 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 14
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 8
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- 230000005669 field effect Effects 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000004306 triazinyl group Chemical group 0.000 claims description 4
- 239000000975 dye Substances 0.000 claims description 3
- 125000003367 polycyclic group Chemical group 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000002950 monocyclic group Chemical group 0.000 claims description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 238000001771 vacuum deposition Methods 0.000 claims description 2
- 125000006527 (C1-C5) alkyl group Chemical group 0.000 claims 1
- 239000010410 layer Substances 0.000 description 107
- -1 and Ph Chemical group 0.000 description 51
- 150000001875 compounds Chemical class 0.000 description 37
- 238000004770 highest occupied molecular orbital Methods 0.000 description 16
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 15
- 239000007983 Tris buffer Substances 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 12
- 238000000295 emission spectrum Methods 0.000 description 12
- 238000002347 injection Methods 0.000 description 12
- 239000007924 injection Substances 0.000 description 12
- 230000005525 hole transport Effects 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 9
- 239000004926 polymethyl methacrylate Substances 0.000 description 9
- 230000000903 blocking effect Effects 0.000 description 8
- 125000001072 heteroaryl group Chemical group 0.000 description 8
- 238000006862 quantum yield reaction Methods 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 5
- 125000005842 heteroatom Chemical group 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 5
- 238000001161 time-correlated single photon counting Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 4
- 239000004305 biphenyl Substances 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 230000005281 excited state Effects 0.000 description 4
- PQXKHYXIUOZZFA-UHFFFAOYSA-M lithium fluoride Chemical compound [Li+].[F-] PQXKHYXIUOZZFA-UHFFFAOYSA-M 0.000 description 4
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 4
- 239000011970 polystyrene sulfonate Substances 0.000 description 4
- 229960002796 polystyrene sulfonate Drugs 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- TVIVIEFSHFOWTE-UHFFFAOYSA-K tri(quinolin-8-yloxy)alumane Chemical compound [Al+3].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 TVIVIEFSHFOWTE-UHFFFAOYSA-K 0.000 description 4
- XOYZGLGJSAZOAG-UHFFFAOYSA-N 1-n,1-n,4-n-triphenyl-4-n-[4-[4-(n-[4-(n-phenylanilino)phenyl]anilino)phenyl]phenyl]benzene-1,4-diamine Chemical compound C1=CC=CC=C1N(C=1C=CC(=CC=1)N(C=1C=CC=CC=1)C=1C=CC(=CC=1)C=1C=CC(=CC=1)N(C=1C=CC=CC=1)C=1C=CC(=CC=1)N(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 XOYZGLGJSAZOAG-UHFFFAOYSA-N 0.000 description 3
- MQRCTQVBZYBPQE-UHFFFAOYSA-N 189363-47-1 Chemical compound C1=CC=CC=C1N(C=1C=C2C3(C4=CC(=CC=C4C2=CC=1)N(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC(=CC=C1C1=CC=C(C=C13)N(C=1C=CC=CC=1)C=1C=CC=CC=1)N(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MQRCTQVBZYBPQE-UHFFFAOYSA-N 0.000 description 3
- GKWLILHTTGWKLQ-UHFFFAOYSA-N 2,3-dihydrothieno[3,4-b][1,4]dioxine Chemical compound O1CCOC2=CSC=C21 GKWLILHTTGWKLQ-UHFFFAOYSA-N 0.000 description 3
- 238000003775 Density Functional Theory Methods 0.000 description 3
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- 239000002019 doping agent Substances 0.000 description 3
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000012736 patent blue V Nutrition 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 238000005424 photoluminescence Methods 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- TXBFHHYSJNVGBX-UHFFFAOYSA-N (4-diphenylphosphorylphenyl)-triphenylsilane Chemical compound C=1C=CC=CC=1P(C=1C=CC(=CC=1)[Si](C=1C=CC=CC=1)(C=1C=CC=CC=1)C=1C=CC=CC=1)(=O)C1=CC=CC=C1 TXBFHHYSJNVGBX-UHFFFAOYSA-N 0.000 description 2
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical compound C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 description 2
- SPDPTFAJSFKAMT-UHFFFAOYSA-N 1-n-[4-[4-(n-[4-(3-methyl-n-(3-methylphenyl)anilino)phenyl]anilino)phenyl]phenyl]-4-n,4-n-bis(3-methylphenyl)-1-n-phenylbenzene-1,4-diamine Chemical compound CC1=CC=CC(N(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC(=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=CC(=CC=2)N(C=2C=C(C)C=CC=2)C=2C=C(C)C=CC=2)C=2C=C(C)C=CC=2)=C1 SPDPTFAJSFKAMT-UHFFFAOYSA-N 0.000 description 2
- XESMNQMWRSEIET-UHFFFAOYSA-N 2,9-dinaphthalen-2-yl-4,7-diphenyl-1,10-phenanthroline Chemical compound C1=CC=CC=C1C1=CC(C=2C=C3C=CC=CC3=CC=2)=NC2=C1C=CC1=C(C=3C=CC=CC=3)C=C(C=3C=C4C=CC=CC4=CC=3)N=C21 XESMNQMWRSEIET-UHFFFAOYSA-N 0.000 description 2
- IXHWGNYCZPISET-UHFFFAOYSA-N 2-[4-(dicyanomethylidene)-2,3,5,6-tetrafluorocyclohexa-2,5-dien-1-ylidene]propanedinitrile Chemical compound FC1=C(F)C(=C(C#N)C#N)C(F)=C(F)C1=C(C#N)C#N IXHWGNYCZPISET-UHFFFAOYSA-N 0.000 description 2
- AWXGSYPUMWKTBR-UHFFFAOYSA-N 4-carbazol-9-yl-n,n-bis(4-carbazol-9-ylphenyl)aniline Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(N(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 AWXGSYPUMWKTBR-UHFFFAOYSA-N 0.000 description 2
- ZOKIJILZFXPFTO-UHFFFAOYSA-N 4-methyl-n-[4-[1-[4-(4-methyl-n-(4-methylphenyl)anilino)phenyl]cyclohexyl]phenyl]-n-(4-methylphenyl)aniline Chemical compound C1=CC(C)=CC=C1N(C=1C=CC(=CC=1)C1(CCCCC1)C=1C=CC(=CC=1)N(C=1C=CC(C)=CC=1)C=1C=CC(C)=CC=1)C1=CC=C(C)C=C1 ZOKIJILZFXPFTO-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 229920001621 AMOLED Polymers 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229910016460 CzSi Inorganic materials 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 101000837344 Homo sapiens T-cell leukemia translocation-altered gene protein Proteins 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 101150027985 NAA35 gene Proteins 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 102100028692 T-cell leukemia translocation-altered gene protein Human genes 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- WIHKEPSYODOQJR-UHFFFAOYSA-N [9-(4-tert-butylphenyl)-6-triphenylsilylcarbazol-3-yl]-triphenylsilane Chemical compound C1=CC(C(C)(C)C)=CC=C1N1C2=CC=C([Si](C=3C=CC=CC=3)(C=3C=CC=CC=3)C=3C=CC=CC=3)C=C2C2=CC([Si](C=3C=CC=CC=3)(C=3C=CC=CC=3)C=3C=CC=CC=3)=CC=C21 WIHKEPSYODOQJR-UHFFFAOYSA-N 0.000 description 2
- XHCLAFWTIXFWPH-UHFFFAOYSA-N [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5] XHCLAFWTIXFWPH-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 238000000065 atmospheric pressure chemical ionisation Methods 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- UFVXQDWNSAGPHN-UHFFFAOYSA-K bis[(2-methylquinolin-8-yl)oxy]-(4-phenylphenoxy)alumane Chemical compound [Al+3].C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC([O-])=CC=C1C1=CC=CC=C1 UFVXQDWNSAGPHN-UHFFFAOYSA-K 0.000 description 2
- XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002800 charge carrier Substances 0.000 description 2
- WDECIBYCCFPHNR-UHFFFAOYSA-N chrysene Chemical compound C1=CC=CC2=CC=C3C4=CC=CC=C4C=CC3=C21 WDECIBYCCFPHNR-UHFFFAOYSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 238000002484 cyclic voltammetry Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000005137 deposition process Methods 0.000 description 2
- IYYZUPMFVPLQIF-UHFFFAOYSA-N dibenzothiophene Chemical compound C1=CC=C2C3=CC=CC=C3SC2=C1 IYYZUPMFVPLQIF-UHFFFAOYSA-N 0.000 description 2
- DKHNGUNXLDCATP-UHFFFAOYSA-N dipyrazino[2,3-f:2',3'-h]quinoxaline-2,3,6,7,10,11-hexacarbonitrile Chemical compound C12=NC(C#N)=C(C#N)N=C2C2=NC(C#N)=C(C#N)N=C2C2=C1N=C(C#N)C(C#N)=N2 DKHNGUNXLDCATP-UHFFFAOYSA-N 0.000 description 2
- 238000000695 excitation spectrum Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 229910000476 molybdenum oxide Inorganic materials 0.000 description 2
- QGLKJKCYBOYXKC-UHFFFAOYSA-N nonaoxidotritungsten Chemical compound O=[W]1(=O)O[W](=O)(=O)O[W](=O)(=O)O1 QGLKJKCYBOYXKC-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- PQQKPALAQIIWST-UHFFFAOYSA-N oxomolybdenum Chemical compound [Mo]=O PQQKPALAQIIWST-UHFFFAOYSA-N 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- RDOWQLZANAYVLL-UHFFFAOYSA-N phenanthridine Chemical compound C1=CC=C2C3=CC=CC=C3C=NC2=C1 RDOWQLZANAYVLL-UHFFFAOYSA-N 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 238000005092 sublimation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 2
- ODHXBMXNKOYIBV-UHFFFAOYSA-N triphenylamine Chemical compound C1=CC=CC=C1N(C=1C=CC=CC=1)C1=CC=CC=C1 ODHXBMXNKOYIBV-UHFFFAOYSA-N 0.000 description 2
- 229910001930 tungsten oxide Inorganic materials 0.000 description 2
- 229910001935 vanadium oxide Inorganic materials 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FNQJDLTXOVEEFB-UHFFFAOYSA-N 1,2,3-benzothiadiazole Chemical compound C1=CC=C2SN=NC2=C1 FNQJDLTXOVEEFB-UHFFFAOYSA-N 0.000 description 1
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical compound C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 description 1
- DXBHBZVCASKNBY-UHFFFAOYSA-N 1,2-Benz(a)anthracene Chemical compound C1=CC=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 DXBHBZVCASKNBY-UHFFFAOYSA-N 0.000 description 1
- UUSUFQUCLACDTA-UHFFFAOYSA-N 1,2-dihydropyrene Chemical compound C1=CC=C2C=CC3=CCCC4=CC=C1C2=C43 UUSUFQUCLACDTA-UHFFFAOYSA-N 0.000 description 1
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 1
- JIHQDMXYYFUGFV-UHFFFAOYSA-N 1,3,5-triazine Chemical compound C1=NC=NC=N1 JIHQDMXYYFUGFV-UHFFFAOYSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical compound N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 1
- ATTVYRDSOVWELU-UHFFFAOYSA-N 1-diphenylphosphoryl-2-(2-diphenylphosphorylphenoxy)benzene Chemical compound C=1C=CC=CC=1P(C=1C(=CC=CC=1)OC=1C(=CC=CC=1)P(=O)(C=1C=CC=CC=1)C=1C=CC=CC=1)(=O)C1=CC=CC=C1 ATTVYRDSOVWELU-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- ZKAMEFMDQNTDFK-UHFFFAOYSA-N 1h-imidazo[4,5-b]pyrazine Chemical compound C1=CN=C2NC=NC2=N1 ZKAMEFMDQNTDFK-UHFFFAOYSA-N 0.000 description 1
- FCTIZUUFUMDWEH-UHFFFAOYSA-N 1h-imidazo[4,5-b]quinoxaline Chemical compound C1=CC=C2N=C(NC=N3)C3=NC2=C1 FCTIZUUFUMDWEH-UHFFFAOYSA-N 0.000 description 1
- GZPPANJXLZUWHT-UHFFFAOYSA-N 1h-naphtho[2,1-e]benzimidazole Chemical compound C1=CC2=CC=CC=C2C2=C1C(N=CN1)=C1C=C2 GZPPANJXLZUWHT-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- STTGYIUESPWXOW-UHFFFAOYSA-N 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline Chemical group C=12C=CC3=C(C=4C=CC=CC=4)C=C(C)N=C3C2=NC(C)=CC=1C1=CC=CC=C1 STTGYIUESPWXOW-UHFFFAOYSA-N 0.000 description 1
- GEQBRULPNIVQPP-UHFFFAOYSA-N 2-[3,5-bis(1-phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole Chemical group C1=CC=CC=C1N1C2=CC=CC=C2N=C1C1=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=CC(C=2N(C3=CC=CC=C3N=2)C=2C=CC=CC=2)=C1 GEQBRULPNIVQPP-UHFFFAOYSA-N 0.000 description 1
- UXGVMFHEKMGWMA-UHFFFAOYSA-N 2-benzofuran Chemical compound C1=CC=CC2=COC=C21 UXGVMFHEKMGWMA-UHFFFAOYSA-N 0.000 description 1
- LYTMVABTDYMBQK-UHFFFAOYSA-N 2-benzothiophene Chemical compound C1=CC=CC2=CSC=C21 LYTMVABTDYMBQK-UHFFFAOYSA-N 0.000 description 1
- HRZTZLCMURHWFY-UHFFFAOYSA-N 2-bromo-1,3-difluorobenzene Chemical compound FC1=CC=CC(F)=C1Br HRZTZLCMURHWFY-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- 125000005916 2-methylpentyl group Chemical group 0.000 description 1
- ZDAWFMCVTXSZTC-UHFFFAOYSA-N 2-n',7-n'-dinaphthalen-1-yl-2-n',7-n'-diphenyl-9,9'-spirobi[fluorene]-2',7'-diamine Chemical compound C1=CC=CC=C1N(C=1C2=CC=CC=C2C=CC=1)C1=CC=C(C=2C(=CC(=CC=2)N(C=2C=CC=CC=2)C=2C3=CC=CC=C3C=CC=2)C23C4=CC=CC=C4C4=CC=CC=C43)C2=C1 ZDAWFMCVTXSZTC-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 1
- WCXKTQVEKDHQIY-UHFFFAOYSA-N 3-[3-[3-(3,5-dipyridin-3-ylphenyl)phenyl]-5-pyridin-3-ylphenyl]pyridine Chemical compound C1=CN=CC(C=2C=C(C=C(C=2)C=2C=NC=CC=2)C=2C=C(C=CC=2)C=2C=C(C=C(C=2)C=2C=NC=CC=2)C=2C=NC=CC=2)=C1 WCXKTQVEKDHQIY-UHFFFAOYSA-N 0.000 description 1
- HCCNHYWZYYIOFM-UHFFFAOYSA-N 3h-benzo[e]benzimidazole Chemical compound C1=CC=C2C(N=CN3)=C3C=CC2=C1 HCCNHYWZYYIOFM-UHFFFAOYSA-N 0.000 description 1
- PWFFDTZNRAEFIY-UHFFFAOYSA-N 4-(4-aminophenyl)-3-(4-methoxyphenyl)aniline Chemical compound C1=CC(OC)=CC=C1C1=CC(N)=CC=C1C1=CC=C(N)C=C1 PWFFDTZNRAEFIY-UHFFFAOYSA-N 0.000 description 1
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- BUADUHVXMFJVLH-UHFFFAOYSA-N 7-chloro-3-imidazol-1-yl-2H-1,2,4-benzotriazin-1-ium 1-oxide Chemical compound N1[N+](=O)C2=CC(Cl)=CC=C2N=C1N1C=CN=C1 BUADUHVXMFJVLH-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- YFHRIUJZXWFFHN-UHFFFAOYSA-N 9-(1-carbazol-9-yl-5-phenylcyclohexa-2,4-dien-1-yl)carbazole Chemical group C=1C=CC(N2C3=CC=CC=C3C3=CC=CC=C32)(N2C3=CC=CC=C3C3=CC=CC=C32)CC=1C1=CC=CC=C1 YFHRIUJZXWFFHN-UHFFFAOYSA-N 0.000 description 1
- MZYDBGLUVPLRKR-UHFFFAOYSA-N 9-(3-carbazol-9-ylphenyl)carbazole Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC(N2C3=CC=CC=C3C3=CC=CC=C32)=CC=C1 MZYDBGLUVPLRKR-UHFFFAOYSA-N 0.000 description 1
- DVNOWTJCOPZGQA-UHFFFAOYSA-N 9-[3,5-di(carbazol-9-yl)phenyl]carbazole Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC(N2C3=CC=CC=C3C3=CC=CC=C32)=CC(N2C3=CC=CC=C3C3=CC=CC=C32)=C1 DVNOWTJCOPZGQA-UHFFFAOYSA-N 0.000 description 1
- WHMHUGLMCAFKFE-UHFFFAOYSA-N 9-[3,5-di(dibenzofuran-2-yl)phenyl]carbazole Chemical compound C1=CC=C2C3=CC(C=4C=C(C=C(C=4)N4C5=CC=CC=C5C5=CC=CC=C54)C4=CC=C5OC=6C(C5=C4)=CC=CC=6)=CC=C3OC2=C1 WHMHUGLMCAFKFE-UHFFFAOYSA-N 0.000 description 1
- MAIALRIWXGBQRP-UHFFFAOYSA-N 9-naphthalen-1-yl-10-naphthalen-2-ylanthracene Chemical compound C12=CC=CC=C2C(C2=CC3=CC=CC=C3C=C2)=C(C=CC=C2)C2=C1C1=CC=CC2=CC=CC=C12 MAIALRIWXGBQRP-UHFFFAOYSA-N 0.000 description 1
- 239000005964 Acibenzolar-S-methyl Substances 0.000 description 1
- 101100383311 Arabidopsis thaliana CESA6 gene Proteins 0.000 description 1
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 101100069857 Caenorhabditis elegans hil-4 gene Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 238000004057 DFT-B3LYP calculation Methods 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- FUJCRWPEOMXPAD-UHFFFAOYSA-N Li2O Inorganic materials [Li+].[Li+].[O-2] FUJCRWPEOMXPAD-UHFFFAOYSA-N 0.000 description 1
- YQOPVCVDSMSYEL-UHFFFAOYSA-N N(2)-{3-[2-(2-{[(1-{N-[(1-{3-[2-(2-{[4-(indol-3-yl)butanoyl]amino}ethoxy)ethoxy]propanoyl}piperidin-4-yl)carbonyl]glycyl}piperidin-4-yl)carbonyl]amino}ethoxy)ethoxy]propanoyl}-N(6)-(5-nitro-2-furoyl)lysinamide Chemical compound C1CN(C(=O)CNC(=O)C2CCN(CC2)C(=O)CCOCCOCCNC(=O)CCCC=2C3=CC=CC=C3NC=2)CCC1C(=O)NCCOCCOCCC(=O)NC(C(=O)N)CCCCNC(=O)C1=CC=C([N+]([O-])=O)O1 YQOPVCVDSMSYEL-UHFFFAOYSA-N 0.000 description 1
- KPZWRGGWUNBLMX-UHFFFAOYSA-N N(6)-[N(6)-(N(6)-{6-[(5-nitro-2-furoyl)amino]hexanoyl}lysyl)lysyl]lysyl-N(6)-[4-(indol-3-yl)butanoyl]lysinamide Chemical compound C=1NC2=CC=CC=C2C=1CCCC(=O)NCCCCC(C(N)=O)NC(=O)C(N)CCCCNC(=O)C(N)CCCCNC(=O)C(N)CCCCNC(=O)CCCCCNC(=O)C1=CC=C([N+]([O-])=O)O1 KPZWRGGWUNBLMX-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 229920000144 PEDOT:PSS Polymers 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- XBDYBAVJXHJMNQ-UHFFFAOYSA-N Tetrahydroanthracene Natural products C1=CC=C2C=C(CCCC3)C3=CC2=C1 XBDYBAVJXHJMNQ-UHFFFAOYSA-N 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000000732 arylene group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- 229910001632 barium fluoride Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005284 basis set Methods 0.000 description 1
- RFRXIWQYSOIBDI-UHFFFAOYSA-N benzarone Chemical compound CCC=1OC2=CC=CC=C2C=1C(=O)C1=CC=C(O)C=C1 RFRXIWQYSOIBDI-UHFFFAOYSA-N 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001716 carbazoles Chemical class 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- RNZVKHIVYDPSBI-UHFFFAOYSA-L copper 2,3,4,5,6-pentafluorobenzoate Chemical compound [Cu++].[O-]C(=O)c1c(F)c(F)c(F)c(F)c1F.[O-]C(=O)c1c(F)c(F)c(F)c(F)c1F RNZVKHIVYDPSBI-UHFFFAOYSA-L 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 101150084411 crn1 gene Proteins 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- JAONJTDQXUSBGG-UHFFFAOYSA-N dialuminum;dizinc;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Zn+2].[Zn+2] JAONJTDQXUSBGG-UHFFFAOYSA-N 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 125000004987 dibenzofuryl group Chemical group C1(=CC=CC=2OC3=C(C21)C=CC=C3)* 0.000 description 1
- ZMQNLWJUMTZMGH-UHFFFAOYSA-N dibenzothiophen-2-yl(diphenyl)silane Chemical compound C1=C(C=CC=2SC3=C(C=21)C=CC=C3)[SiH](C1=CC=CC=C1)C1=CC=CC=C1 ZMQNLWJUMTZMGH-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- XUCJHNOBJLKZNU-UHFFFAOYSA-M dilithium;hydroxide Chemical compound [Li+].[Li+].[OH-] XUCJHNOBJLKZNU-UHFFFAOYSA-M 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 238000001194 electroluminescence spectrum Methods 0.000 description 1
- 238000004993 emission spectroscopy Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- JKFAIQOWCVVSKC-UHFFFAOYSA-N furazan Chemical compound C=1C=NON=1 JKFAIQOWCVVSKC-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002390 heteroarenes Chemical class 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000005980 hexynyl group Chemical group 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- HOBCFUWDNJPFHB-UHFFFAOYSA-N indolizine Chemical compound C1=CC=CN2C=CC=C21 HOBCFUWDNJPFHB-UHFFFAOYSA-N 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- YEXPOXQUZXUXJW-UHFFFAOYSA-N lead(II) oxide Inorganic materials [Pb]=O YEXPOXQUZXUXJW-UHFFFAOYSA-N 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- FQHFBFXXYOQXMN-UHFFFAOYSA-M lithium;quinolin-8-olate Chemical compound [Li+].C1=CN=C2C([O-])=CC=CC2=C1 FQHFBFXXYOQXMN-UHFFFAOYSA-M 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000005244 neohexyl group Chemical group [H]C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000005069 octynyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C#C* 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 150000004866 oxadiazoles Chemical class 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- SLIUAWYAILUBJU-UHFFFAOYSA-N pentacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C21 SLIUAWYAILUBJU-UHFFFAOYSA-N 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 150000003004 phosphinoxides Chemical class 0.000 description 1
- 238000001296 phosphorescence spectrum Methods 0.000 description 1
- 238000000628 photoluminescence spectroscopy Methods 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000767 polyaniline Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 238000000275 quality assurance Methods 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000003115 supporting electrolyte Substances 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- IFLREYGFSNHWGE-UHFFFAOYSA-N tetracene Chemical compound C1=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C21 IFLREYGFSNHWGE-UHFFFAOYSA-N 0.000 description 1
- 125000005309 thioalkoxy group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 229910001887 tin oxide Inorganic materials 0.000 description 1
- QHGNHLZPVBIIPX-UHFFFAOYSA-N tin(II) oxide Inorganic materials [Sn]=O QHGNHLZPVBIIPX-UHFFFAOYSA-N 0.000 description 1
- 229910052723 transition metal Chemical class 0.000 description 1
- 229910000314 transition metal oxide Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 125000005259 triarylamine group Chemical group 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- SLGBZMMZGDRARJ-UHFFFAOYSA-N triphenylene Chemical compound C1=CC=C2C3=CC=CC=C3C3=CC=CC=C3C2=C1 SLGBZMMZGDRARJ-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 238000005019 vapor deposition process Methods 0.000 description 1
- 238000001947 vapour-phase growth Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E10/00—Energy generation through renewable energy sources
- Y02E10/50—Photovoltaic [PV] energy
- Y02E10/549—Organic PV cells
Landscapes
- Electroluminescent Light Sources (AREA)
Abstract
The invention relates to an organic compound, in particular for the use in optoelectronic devices. According to the invention, the organic compound has a structure of Formula l, (see formula I) wherein X is N or CR3; R1, R2, R3, R I, R II, R III, R IV, R V, R VI, R VII, R VIII, R IX, R X, R XI and R XII is independently from each other selected from the group consisting of: hydrogen, deuterium, C1-C40-alkyl, which is optionally substituted with one or more substituents R4; C1-C40-alkoxyl, which is optionally substituted with one or more substituents R4; C2-C43-alkenyl, which is optionally substituted with one or more substituents R4; C2-C40-alkynyl, which is optionally substituted with one or more substituents R4; C6-C60-aryl, which is optionally substituted with one or more substituents R4; C3-C57-heteroaryl, which is optionally substituted with one or more substituents R4; CN; CF3; N(R4)2; OR4, and Si(R4)3.
Description
I
ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES
The invention relates to organic light-emitting molecules and their use in organic light-emitting diodes (OLEDs) and in other optoelectronic devices.
Description The object of the present invention is to provide molecules which are suitable for use in optoelectronic devices.
This object is achieved by the invention which provides a new class of organic molecules.
According to the invention the organic molecules are purely organic molecules, i.e. they do not contain any metal ions in contrast to metal complexes known for use in optoelectronic devices.
According to the present invention, the organic molecules exhibit emission maxima in the blue, sky-blue or green spectral range. The organic molecules exhibit in particular emission maxima between 420 nm and 520 nm, preferably between 440 nm and 495 nm, more preferably between 450 nm and 470 nm. The photoluminescence quantum yields of the organic molecules according to the invention are, in particular, 20 % or more. The use of the molecules according to the invention in an optoelectronic device, for example an organic light-emitting diode (OLED), leads to higher efficiencies or higher color purity, expressed by the full width at half maximum (FWHM) of emission, of the device. Corresponding OLEDs have a higher stability than OLEDs with known emitter materials and comparable color.
The organic light-emitting molecule of the invention comprises or consists of a structure of Formula I, R" ' R"vi "
p, -vii -Rix R'v Rx 0 B Rill Rx, / \ NjxN / \ R"
Rx" R1X R2 RI
Formula I
ORGANIC MOLECULES, IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES
The invention relates to organic light-emitting molecules and their use in organic light-emitting diodes (OLEDs) and in other optoelectronic devices.
Description The object of the present invention is to provide molecules which are suitable for use in optoelectronic devices.
This object is achieved by the invention which provides a new class of organic molecules.
According to the invention the organic molecules are purely organic molecules, i.e. they do not contain any metal ions in contrast to metal complexes known for use in optoelectronic devices.
According to the present invention, the organic molecules exhibit emission maxima in the blue, sky-blue or green spectral range. The organic molecules exhibit in particular emission maxima between 420 nm and 520 nm, preferably between 440 nm and 495 nm, more preferably between 450 nm and 470 nm. The photoluminescence quantum yields of the organic molecules according to the invention are, in particular, 20 % or more. The use of the molecules according to the invention in an optoelectronic device, for example an organic light-emitting diode (OLED), leads to higher efficiencies or higher color purity, expressed by the full width at half maximum (FWHM) of emission, of the device. Corresponding OLEDs have a higher stability than OLEDs with known emitter materials and comparable color.
The organic light-emitting molecule of the invention comprises or consists of a structure of Formula I, R" ' R"vi "
p, -vii -Rix R'v Rx 0 B Rill Rx, / \ NjxN / \ R"
Rx" R1X R2 RI
Formula I
2 X is N or CR3.
R1, R2, R3, RI, RH, RH!, RIV, Rv, RNA, Rvni, Rix, Rx, Rxl and Rxil is independently from each other selected from the group consisting of:
hydrogen, deuterium, C1-C40-alkyl, which is optionally substituted with one or more substituents R4;
C1-C40-alkoxyl, which is optionally substituted with one or more substituents R4;
C2-C40-alkenyl, which is optionally substituted with one or more substituents R4;
C2-C40-alkynyl, which is optionally substituted with one or more substituents R4;
C6-C60-aryl, which is optionally substituted with one or more substituents R4;
C3-057-heteroaryl, which is optionally substituted with one or more substituents R4;
CN, CF3, N(R4)2, OR4, and Si(R4)3.
R4 is at each occurrence independently from another selected from the group consisting of:
hydrogen, deuterium, OPh, CF3, CN, F, C1-05-a1ky1, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C1-05-alkoxy, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C1-05-thioalkwry, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C2-05-alkenyl, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C2-05-alkynyl,
R1, R2, R3, RI, RH, RH!, RIV, Rv, RNA, Rvni, Rix, Rx, Rxl and Rxil is independently from each other selected from the group consisting of:
hydrogen, deuterium, C1-C40-alkyl, which is optionally substituted with one or more substituents R4;
C1-C40-alkoxyl, which is optionally substituted with one or more substituents R4;
C2-C40-alkenyl, which is optionally substituted with one or more substituents R4;
C2-C40-alkynyl, which is optionally substituted with one or more substituents R4;
C6-C60-aryl, which is optionally substituted with one or more substituents R4;
C3-057-heteroaryl, which is optionally substituted with one or more substituents R4;
CN, CF3, N(R4)2, OR4, and Si(R4)3.
R4 is at each occurrence independently from another selected from the group consisting of:
hydrogen, deuterium, OPh, CF3, CN, F, C1-05-a1ky1, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C1-05-alkoxy, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C1-05-thioalkwry, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C2-05-alkenyl, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C2-05-alkynyl,
3 wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
06-018-aryl, which is optionally substituted with one or more Cl-05-alkyl substituents;
C3-C17-heteroaryl, which is optionally substituted with one or more C1-05-alkyl substituents;
N(C6-C18-ary1)2, N(C3-C17-heteroary1)2, and N(C3-017-heteroary1)(C6-C18-aryl).
Optionally, pairs of two substituents selected from the group consisting of Rix and Will, RvIII and RvI and IR", and Rv and RI" form a monocyclic or polycyclic, aliphatic, aromatic and/or benzo-fused ring system with each other.
In a further embodiment of the invention, R1, R2, R3, RI, RH, Rill, Rv, Rx, Rxi and RxII is independently from another selected from the group consisting of:
hydrogen, deuterium, halogen, Me, 'Pr, 'Bu, CN, CF3, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, pyridinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, pyrimidinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, triazinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, 'Bu, CN, CF3, and Ph, and N(Ph)2.
In a further embodiment of the invention, R3, RI, Rill, RIV, Rvi, Rvii,RD, Rx and Rx is independently from another selected from the group consisting of:
hydrogen, deuterium, halogen, Me, 'Pr, 'Bu, CN, CF3, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, pyridinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph,
06-018-aryl, which is optionally substituted with one or more Cl-05-alkyl substituents;
C3-C17-heteroaryl, which is optionally substituted with one or more C1-05-alkyl substituents;
N(C6-C18-ary1)2, N(C3-C17-heteroary1)2, and N(C3-017-heteroary1)(C6-C18-aryl).
Optionally, pairs of two substituents selected from the group consisting of Rix and Will, RvIII and RvI and IR", and Rv and RI" form a monocyclic or polycyclic, aliphatic, aromatic and/or benzo-fused ring system with each other.
In a further embodiment of the invention, R1, R2, R3, RI, RH, Rill, Rv, Rx, Rxi and RxII is independently from another selected from the group consisting of:
hydrogen, deuterium, halogen, Me, 'Pr, 'Bu, CN, CF3, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, pyridinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, pyrimidinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, triazinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, 'Bu, CN, CF3, and Ph, and N(Ph)2.
In a further embodiment of the invention, R3, RI, Rill, RIV, Rvi, Rvii,RD, Rx and Rx is independently from another selected from the group consisting of:
hydrogen, deuterium, halogen, Me, 'Pr, 'Bu, CN, CF3, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph, pyridinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, Su, CN, CF3, and Ph,
4 pyrimidinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, CN, CF3, and Ph, and triazinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, CN, CF3, and Ph;
and R1, R2, RH, 1-1 ¨v, R"II and Rxl is independently from another selected from the group consisting of:
hydrogen, deuterium, Me, iPr, tBu, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, CN, CF3, and Ph, and N(Ph)2.
In a further embodiment of the invention, R3, RI, RI , RI", RvI, Rx and Rx II is independently from another selected from the group consisting of hydrogen, deuterium, Me, 'Pr, tBu, CN, CF3, and Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, CN, CF3, and Ph; and R1, R2, RvIII
and RxI is independently from another selected from the group consisting of hydrogen, deuterium, Me, 'Pr, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, tBu, and Ph;
and N(Ph)2.
In one embodiment, RI, Rill, RIV, Rv, will, Rx, and ¨xi are each H.
In one embodiment, R2 and R1 are the same residue.
In one embodiment, R1, R2, R3, RI, RH, Rill, Rw, Rv, Rv1, ivy, RIX, Rx, and rc ¨xi are each H.
In a further embodiment of the invention, the organic molecules consist of a structure of one of Formulas ll to XXI:
and R1, R2, RH, 1-1 ¨v, R"II and Rxl is independently from another selected from the group consisting of:
hydrogen, deuterium, Me, iPr, tBu, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, CN, CF3, and Ph, and N(Ph)2.
In a further embodiment of the invention, R3, RI, RI , RI", RvI, Rx and Rx II is independently from another selected from the group consisting of hydrogen, deuterium, Me, 'Pr, tBu, CN, CF3, and Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, CN, CF3, and Ph; and R1, R2, RvIII
and RxI is independently from another selected from the group consisting of hydrogen, deuterium, Me, 'Pr, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, 'Pr, tBu, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, tBu, and Ph;
and N(Ph)2.
In one embodiment, RI, Rill, RIV, Rv, will, Rx, and ¨xi are each H.
In one embodiment, R2 and R1 are the same residue.
In one embodiment, R1, R2, R3, RI, RH, Rill, Rw, Rv, Rv1, ivy, RIX, Rx, and rc ¨xi are each H.
In a further embodiment of the invention, the organic molecules consist of a structure of one of Formulas ll to XXI:
5 B
B
¨N
110 N¨ ¨N
N Formula II Formula Ill Ill B
B
N / \
¨N
1101 N¨ ¨N I
el Formula IV Formula V
B
B
/ \ L/ \ N*N
/ \ N (10 ¨N N¨ ¨N
N N¨
II
Formula VI Formula V
/\ N is N /\ / \ N.,,(L, N /\
¨N N¨ ¨N i N¨
N
Formula VIII Formula IX
B
¨N
110 N¨ ¨N
N Formula II Formula Ill Ill B
B
N / \
¨N
1101 N¨ ¨N I
el Formula IV Formula V
B
B
/ \ L/ \ N*N
/ \ N (10 ¨N N¨ ¨N
N N¨
II
Formula VI Formula V
/\ N is N /\ / \ N.,,(L, N /\
¨N N¨ ¨N i N¨
N
Formula VIII Formula IX
6 41 IP 0$
,N N * * N N .
B B
/ \ N 0 N
-N N-,N
Formula X Formula XI
N N N N
B B
/ \ N 401 N
-N N-N
Formula XII Formula XIII
B B
-N
N N
Formula XIV Formula XV
,N N * * N N .
B B
/ \ N 0 N
-N N-,N
Formula X Formula XI
N N N N
B B
/ \ N 401 N
-N N-N
Formula XII Formula XIII
B B
-N
N N
Formula XIV Formula XV
7 B B
cc cc N-I. 0 IS
Formula XVI Formula XVII
B B
Si N-N N INI- N
I I
Formula XVIII Formula XIX
B B
I
I
N 401 N (00/
Formula XX Formula XXI
As used throughout the present application, the terms "aryl" and "aromatic"
may be understood in the broadest sense as any mono-, bi- or polycyclic aromatic moieties.
Accordingly, an aryl group contains 6 to 60 aromatic ring atoms, and a heteroaryl group contains 5 to 60 aromatic ring atoms,
cc cc N-I. 0 IS
Formula XVI Formula XVII
B B
Si N-N N INI- N
I I
Formula XVIII Formula XIX
B B
I
I
N 401 N (00/
Formula XX Formula XXI
As used throughout the present application, the terms "aryl" and "aromatic"
may be understood in the broadest sense as any mono-, bi- or polycyclic aromatic moieties.
Accordingly, an aryl group contains 6 to 60 aromatic ring atoms, and a heteroaryl group contains 5 to 60 aromatic ring atoms,
8 of which at least one is a heteroatom. Notwithstanding, throughout the application the number of aromatic ring atoms may be given as subscripted number in the definition of certain substituents.
In particular, the heteroaromatic ring includes one to three heteroatoms.
Again, the terms "heteroaryl" and "heteroaromatic" may be understood in the broadest sense as any mono-, bi- or polycyclic hetero-aromatic moieties that include at least one heteroatom. The heteroatoms may at each occurrence be the same or different and be individually selected from the group consisting of N, 0 and S. Accordingly, the term "arylene" refers to a divalent substituent that bears two binding sites to other molecular structures and thereby serving as a linker structure. In case, a group in the exemplary embodiments is defined differently from the definitions given here, for example, the number of aromatic ring atoms or number of heteroatoms differs from the given definition, the definition in the exemplary embodiments is to be applied.
According to the invention, a condensed (annulated) aromatic or heteroaromatic polycycle is built of two or more single aromatic or heteroaromatic cycles, which formed the polycycle via a condensation reaction.
In particular, as used throughout the present application, the term "aryl group or heteroaryl group"
comprises groups which can be bound via any position of the aromatic or heteroaromatic group, derived from benzene, naphthaline, anthracene, phenanthrene, pyrene, dihydropyrene, chrysene, perylene, fluoranthene, benzanthracene, benzphenanthrene, tetracene, pentacene, benzpyrene, furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene; pyrrole, indole, isoindole, carbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, phenothiazine, phenoxazine, pyrazole, indazole, imidazole, benzimidazole, naphthoimidazole, phenanthroimidazole, pyridoimidazole, pyrazinoimidazole, quinoxalinoimidazole, oxazole, benzoxazole, napthooxazole, anthroxazol, phenanthroxazol, isoxazole, 1,2-thiazole, 1,3-thiazole, benzothiazole, pyridazine, benzopyridazine, pyrimidine, benzopyrimidine, 1,3,5-triazine, quinoxaline, pyrazine, phenazine, naphthyridine, carboline, benzocarboline, phenanthroline, 1,2,3-triazole, 1,2,4-triazole, benzotriazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,2,3,4-tetrazine, purine, pteridine, indolizine and benzothiadiazole or combinations of the abovementioned groups.
As used throughout the present application, the term "cyclic group" may be understood in the broadest sense as any mono-, bi- or polycyclic moieties.
In particular, the heteroaromatic ring includes one to three heteroatoms.
Again, the terms "heteroaryl" and "heteroaromatic" may be understood in the broadest sense as any mono-, bi- or polycyclic hetero-aromatic moieties that include at least one heteroatom. The heteroatoms may at each occurrence be the same or different and be individually selected from the group consisting of N, 0 and S. Accordingly, the term "arylene" refers to a divalent substituent that bears two binding sites to other molecular structures and thereby serving as a linker structure. In case, a group in the exemplary embodiments is defined differently from the definitions given here, for example, the number of aromatic ring atoms or number of heteroatoms differs from the given definition, the definition in the exemplary embodiments is to be applied.
According to the invention, a condensed (annulated) aromatic or heteroaromatic polycycle is built of two or more single aromatic or heteroaromatic cycles, which formed the polycycle via a condensation reaction.
In particular, as used throughout the present application, the term "aryl group or heteroaryl group"
comprises groups which can be bound via any position of the aromatic or heteroaromatic group, derived from benzene, naphthaline, anthracene, phenanthrene, pyrene, dihydropyrene, chrysene, perylene, fluoranthene, benzanthracene, benzphenanthrene, tetracene, pentacene, benzpyrene, furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene; pyrrole, indole, isoindole, carbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5,6-quinoline, benzo-6,7-quinoline, benzo-7,8-quinoline, phenothiazine, phenoxazine, pyrazole, indazole, imidazole, benzimidazole, naphthoimidazole, phenanthroimidazole, pyridoimidazole, pyrazinoimidazole, quinoxalinoimidazole, oxazole, benzoxazole, napthooxazole, anthroxazol, phenanthroxazol, isoxazole, 1,2-thiazole, 1,3-thiazole, benzothiazole, pyridazine, benzopyridazine, pyrimidine, benzopyrimidine, 1,3,5-triazine, quinoxaline, pyrazine, phenazine, naphthyridine, carboline, benzocarboline, phenanthroline, 1,2,3-triazole, 1,2,4-triazole, benzotriazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1,2,3,4-tetrazine, purine, pteridine, indolizine and benzothiadiazole or combinations of the abovementioned groups.
As used throughout the present application, the term "cyclic group" may be understood in the broadest sense as any mono-, bi- or polycyclic moieties.
9 As used throughout the present application, the term "biphenyl" as a substituent may be understood in the broadest sense as ortho-biphenyl, meta-biphenyl, or para-biphenyl, wherein ortho, meta and para is defined in regard to the binding site to another chemical moiety.
As used throughout the present application, the term "alkyl group" may be understood in the broadest sense as any linear, branched, or cyclic alkyl substituent. In particular, the term alkyl comprises the substituents methyl (Me), ethyl (Et), n-propyl (Tr), i-propyl ('Pr), cyclopropyl, n-butyl ("Bu), i-butyl ('Bu), s-butyl (Bu), t-butyl ('Bu), cyclobutyl, 2-methylbutyl, n-pentyl, s-pentyl, t-pentyl, 2-pentyl, neo-pentyl, cyclopentyl, n-hexyl, s-hexyl, t-hexyl, 2-hexyl, 3-hexyl, neo-hexyl, cyclohexyl, 1-methylcyclopentyl, 2-methylpentyl, n-heptyl, 2-heptyl, 3-heptyl, 4-heptyl, cycloheptyl, 1-methylcyclohexyl, n-octyl, 2-ethylhexyl, cyclooctyl, 1-bicyclo[2,2,2]octyl, 2-bicyclo[2,2,2]-octyl, 2-(2,6-dimethyl)octyl, 3-(3,7-dimethyl)octyl, adamantyl, 2,2,2-trifluorethyl, 1 ,1-dimethyl-n-hex-1-yl, 1 ,1-dimethyl-n-hept-1-yl, 1 ,1-dimethyl-n-oct-1-yl, 1 ,1-dimethyl-n-dec-1-yl, 1,1-dimethyl-n-dodec-1-yl, 1,1-dimethyl-n-tetradec-1-yl, 1,1-dimethyl-n-hexadec-1-yl, 1,1-dimethyl-n-octadec-1 -yl, 1 ,1-diethyl-n-hex-1-yl, 1 ,1-diethyl-n-hept-1-yl, 1 ,1-diethyl-n-oct-1-yl, 1 ,1-diethyl-n-dec-1-yl, 1 ,1-diethyl-n-dodec-1-yl, 1 ,1-diethyl-n-tetradec-1-yl, 1 ,1-diethyln-n-hexadec-1-yl, 1 ,1-diethyl-n-octadec-1-yl, 1-(n-propyI)-cyclohex-1-yl, 1 -(n-buty1)-cyclohex-1 -yl, 1 -(n-hexyl)-cyclohex-1 -yl, 1 -(n-octyI)-cyclohex-1 -yl and 1 -(n-decy1)-cyclohex-1-yl.
As used throughout the present application, the term "alkenyl" comprises linear, branched, and cyclic alkenyl substituents. The term alkenyl group exemplarily comprises the substituents ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl or cyclooctadienyl.
As used throughout the present application, the term "alkynyl" comprises linear, branched, and cyclic alkynyl substituents. The term alkynyl group exemplarily comprises ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl or octynyl.
As used throughout the present application, the term "alkoxy" comprises linear, branched, and cyclic alkoxy substituents. The term alkoxy group exemplarily comprises methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, s-butoxy, t-butoxy and 2-methylbutoxy.
As used throughout the present application, the term "thioalkoxy" comprises linear, branched, and cyclic thioalkoxy substituents, in which the 0 of the exemplarily alkoxy groups is replaced by S.
As used throughout the present application, the term "alkyl group" may be understood in the broadest sense as any linear, branched, or cyclic alkyl substituent. In particular, the term alkyl comprises the substituents methyl (Me), ethyl (Et), n-propyl (Tr), i-propyl ('Pr), cyclopropyl, n-butyl ("Bu), i-butyl ('Bu), s-butyl (Bu), t-butyl ('Bu), cyclobutyl, 2-methylbutyl, n-pentyl, s-pentyl, t-pentyl, 2-pentyl, neo-pentyl, cyclopentyl, n-hexyl, s-hexyl, t-hexyl, 2-hexyl, 3-hexyl, neo-hexyl, cyclohexyl, 1-methylcyclopentyl, 2-methylpentyl, n-heptyl, 2-heptyl, 3-heptyl, 4-heptyl, cycloheptyl, 1-methylcyclohexyl, n-octyl, 2-ethylhexyl, cyclooctyl, 1-bicyclo[2,2,2]octyl, 2-bicyclo[2,2,2]-octyl, 2-(2,6-dimethyl)octyl, 3-(3,7-dimethyl)octyl, adamantyl, 2,2,2-trifluorethyl, 1 ,1-dimethyl-n-hex-1-yl, 1 ,1-dimethyl-n-hept-1-yl, 1 ,1-dimethyl-n-oct-1-yl, 1 ,1-dimethyl-n-dec-1-yl, 1,1-dimethyl-n-dodec-1-yl, 1,1-dimethyl-n-tetradec-1-yl, 1,1-dimethyl-n-hexadec-1-yl, 1,1-dimethyl-n-octadec-1 -yl, 1 ,1-diethyl-n-hex-1-yl, 1 ,1-diethyl-n-hept-1-yl, 1 ,1-diethyl-n-oct-1-yl, 1 ,1-diethyl-n-dec-1-yl, 1 ,1-diethyl-n-dodec-1-yl, 1 ,1-diethyl-n-tetradec-1-yl, 1 ,1-diethyln-n-hexadec-1-yl, 1 ,1-diethyl-n-octadec-1-yl, 1-(n-propyI)-cyclohex-1-yl, 1 -(n-buty1)-cyclohex-1 -yl, 1 -(n-hexyl)-cyclohex-1 -yl, 1 -(n-octyI)-cyclohex-1 -yl and 1 -(n-decy1)-cyclohex-1-yl.
As used throughout the present application, the term "alkenyl" comprises linear, branched, and cyclic alkenyl substituents. The term alkenyl group exemplarily comprises the substituents ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl or cyclooctadienyl.
As used throughout the present application, the term "alkynyl" comprises linear, branched, and cyclic alkynyl substituents. The term alkynyl group exemplarily comprises ethynyl, propynyl, butynyl, pentynyl, hexynyl, heptynyl or octynyl.
As used throughout the present application, the term "alkoxy" comprises linear, branched, and cyclic alkoxy substituents. The term alkoxy group exemplarily comprises methoxy, ethoxy, n-propoxy, i-propoxy, n-butoxy, s-butoxy, t-butoxy and 2-methylbutoxy.
As used throughout the present application, the term "thioalkoxy" comprises linear, branched, and cyclic thioalkoxy substituents, in which the 0 of the exemplarily alkoxy groups is replaced by S.
10 As used throughout the present application, the terms "halogen" and "halo" may be understood in the broadest sense as being preferably fluorine, chlorine, bromine or iodine.
Whenever hydrogen (H) is mentioned herein, it could also be replaced by deuterium at each occurrence.
It is understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. naphtyl, dibenzofuryl) or as if it were the whole molecule (e.g. naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.
In one embodiment, the organic molecules according to the invention have an excited state lifetime of not more than 150 ps, of not more than 100 ps, in particular of not more than 50 ps, more preferably of not more than 10 ps or not more than 7 ps in a film of poly(methyl methacrylate) (PMMA) with 10% by weight of organic molecule at room temperature.
In a further embodiment of the invention, the organic molecules according to the invention have an emission peak in the visible or nearest ultraviolet range, i.e., in the range of a wavelength of from 380 to 800 nnn, with a full width at half maximum of less than 0.40 eV, preferably less than 0.35 eV, more preferably less than 0.33 eV, even more preferably less than 0.30 eV or even less than 0.28 eV in a film of poly(methyl methacrylate) (PMMA) with 10 % by weight of organic molecule at room temperature.
Orbital and excited state energies can be determined either by means of experimental methods or by calculations employing quantum-chemical methods, in particular density functional theory calculations. The energy of the highest occupied molecular orbital EH m is determined by methods known to the person skilled in the art from cyclic voltammetry measurements with an accuracy of 0.1 eV. The energy of the lowest unoccupied molecular orbital ELum is calculated as EHomo Egapy wherein EgaP is determined as follows: For host compounds, the onset of the emission spectrum of a film with 10 % by weight of host in poly(methyl methacrylate) (PMMA) is used as EgaP, unless stated otherwise. For emitter molecules, EP is determined as the energy at which the excitation and emission spectra of a film with 10 % by weight of emitter in PMMA cross.
Whenever hydrogen (H) is mentioned herein, it could also be replaced by deuterium at each occurrence.
It is understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. naphtyl, dibenzofuryl) or as if it were the whole molecule (e.g. naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.
In one embodiment, the organic molecules according to the invention have an excited state lifetime of not more than 150 ps, of not more than 100 ps, in particular of not more than 50 ps, more preferably of not more than 10 ps or not more than 7 ps in a film of poly(methyl methacrylate) (PMMA) with 10% by weight of organic molecule at room temperature.
In a further embodiment of the invention, the organic molecules according to the invention have an emission peak in the visible or nearest ultraviolet range, i.e., in the range of a wavelength of from 380 to 800 nnn, with a full width at half maximum of less than 0.40 eV, preferably less than 0.35 eV, more preferably less than 0.33 eV, even more preferably less than 0.30 eV or even less than 0.28 eV in a film of poly(methyl methacrylate) (PMMA) with 10 % by weight of organic molecule at room temperature.
Orbital and excited state energies can be determined either by means of experimental methods or by calculations employing quantum-chemical methods, in particular density functional theory calculations. The energy of the highest occupied molecular orbital EH m is determined by methods known to the person skilled in the art from cyclic voltammetry measurements with an accuracy of 0.1 eV. The energy of the lowest unoccupied molecular orbital ELum is calculated as EHomo Egapy wherein EgaP is determined as follows: For host compounds, the onset of the emission spectrum of a film with 10 % by weight of host in poly(methyl methacrylate) (PMMA) is used as EgaP, unless stated otherwise. For emitter molecules, EP is determined as the energy at which the excitation and emission spectra of a film with 10 % by weight of emitter in PMMA cross.
11 The energy of the first excited triplet state Ti is determined from the onset of the emission spectrum at low temperature, typically at 77 K. For host compounds, where the first excited singlet state and the lowest triplet state are energetically separated by > 0.4 eV, the phosphorescence is usually visible in a steady-state spectrum in 2-Me-THF. The triplet energy can thus be determined as the onset of the phosphorescence spectrum. For TADF emitter molecules, the energy of the first excited triplet state T1 is determined from the onset of the delayed emission spectrum at 77 K, if not otherwise stated, measured in a film of PMMA with 10 % by weight of emitter. Both for host and emitter compounds, the energy of the first excited singlet state Si is determined from the onset of the emission spectrum, if not otherwise stated, measured in a film of PMMA with % by weight of host or emitter compound.
The onset of an emission spectrum is determined by computing the intersection of the tangent to the emission spectrum with the x-axis. The tangent to the emission spectrum is set at the high-energy side of the emission band and at the point at half maximum of the maximum intensity of the emission spectrum.
A further aspect of the invention relates to a process for preparing the organic molecule of the invention (with an optional subsequent reaction), wherein tert-buthyllithium (iBuLi) and boron tribromide (BBr3) is used as a reactant:
lX Rix R" R R Rxi I x" Rxi Rviii Rxii \ / Rvu Br N N
N + Fk.,.,F Riv Br Rix N NaH N N
H CI I __________ u , RV \j\ Rviii Rill Riv R.IXR2 dry toluene Rii Rv 120 C Rvi CI rX\ CI Rvii RI \ / Rvi R2 R1 N
N
H CI
RII RI
RII Rxi RI" / \ N
Ri Rxii Rv Riv --- R2 -78 Rv N
N N tBuLi N*
Riv Br --- Rix BBr3 I
). =--, 1 ,,i) N
B R I Rviu dry THF C Rvi N
Rvi CI r)e\ CI Rvii Rvii / N\ RxII
Rviii R
Rix Rx
The onset of an emission spectrum is determined by computing the intersection of the tangent to the emission spectrum with the x-axis. The tangent to the emission spectrum is set at the high-energy side of the emission band and at the point at half maximum of the maximum intensity of the emission spectrum.
A further aspect of the invention relates to a process for preparing the organic molecule of the invention (with an optional subsequent reaction), wherein tert-buthyllithium (iBuLi) and boron tribromide (BBr3) is used as a reactant:
lX Rix R" R R Rxi I x" Rxi Rviii Rxii \ / Rvu Br N N
N + Fk.,.,F Riv Br Rix N NaH N N
H CI I __________ u , RV \j\ Rviii Rill Riv R.IXR2 dry toluene Rii Rv 120 C Rvi CI rX\ CI Rvii RI \ / Rvi R2 R1 N
N
H CI
RII RI
RII Rxi RI" / \ N
Ri Rxii Rv Riv --- R2 -78 Rv N
N N tBuLi N*
Riv Br --- Rix BBr3 I
). =--, 1 ,,i) N
B R I Rviu dry THF C Rvi N
Rvi CI r)e\ CI Rvii Rvii / N\ RxII
Rviii R
Rix Rx
12 A further aspect of the invention relates to the use of an organic molecule of the invention as a luminescent emitter or as an absorber, and/or as a host material and/or as an electron transport material, and/or as a hole injection material, and/or as a hole blocking material in an optoelectronic device.
A preferred embodiment relates to the use of an organic molecule according to the invention as a luminescent emitter in an optoelectronic device.
The optoelectronic device may be understood in the broadest sense as any device based on organic materials that is suitable for emitting light in the visible or nearest ultraviolet (UV) range, i.e., in the range of a wavelength of from 380 to 800 nm. More preferably, organic electroluminescent device may be able to emit light in the visible range, i.e., of from 400 nm to 800 nm.
In the context of such use, the optoelectronic device is more particularly selected from the group consisting of:
= organic light-emitting diodes (OLEDs), = light-emitting electrochemical cells, = OLED sensors, especially in gas and vapor sensors that are not hermetically shielded to the surroundings, = organic diodes, = organic solar cells, = organic transistors, = organic field-effect transistors, = organic lasers and = down-conversion elements.
In a preferred embodiment in the context of such use, the organic electroluminescent device is a device selected from the group consisting of an organic light emitting diode (OLED), a light emitting electrochemical cell (LEC), and a light-emitting transistor.
In the case of the use, the fraction of the organic molecule according to the invention in the emission layer in an optoelectronic device, more particularly in an OLED, is 1 % to 99 % by weight,
A preferred embodiment relates to the use of an organic molecule according to the invention as a luminescent emitter in an optoelectronic device.
The optoelectronic device may be understood in the broadest sense as any device based on organic materials that is suitable for emitting light in the visible or nearest ultraviolet (UV) range, i.e., in the range of a wavelength of from 380 to 800 nm. More preferably, organic electroluminescent device may be able to emit light in the visible range, i.e., of from 400 nm to 800 nm.
In the context of such use, the optoelectronic device is more particularly selected from the group consisting of:
= organic light-emitting diodes (OLEDs), = light-emitting electrochemical cells, = OLED sensors, especially in gas and vapor sensors that are not hermetically shielded to the surroundings, = organic diodes, = organic solar cells, = organic transistors, = organic field-effect transistors, = organic lasers and = down-conversion elements.
In a preferred embodiment in the context of such use, the organic electroluminescent device is a device selected from the group consisting of an organic light emitting diode (OLED), a light emitting electrochemical cell (LEC), and a light-emitting transistor.
In the case of the use, the fraction of the organic molecule according to the invention in the emission layer in an optoelectronic device, more particularly in an OLED, is 1 % to 99 % by weight,
13 more particularly 3 % to 80 % by weight. In an alternative embodiment, the proportion of the organic molecule in the emission layer is 100 % by weight.
In one embodiment, the light-emitting layer comprises not only the organic molecules according to the invention, but also a host material whose triplet (T1) and singlet (S1) energy levels are energetically higher than the triplet (T1) and singlet (S1) energy levels of the organic molecule.
A further aspect of the invention relates to a composition comprising or consisting of:
(a) at least one organic molecule according to the invention, in particular in the form of an emitter and/or a host, and (b) one or more emitter and/or host materials, which differ from the organic molecule according to the invention and (c) optional one or more dyes and/or one or more solvents.
In one embodiment, the light-emitting layer comprises (or essentially consists of) a composition comprising or consisting of:
(a) at least one organic molecule according to the invention, in particular in the form of an emitter and/or a host, and (b) one or more emitter and/or host materials, which differ from the organic molecule according to the invention and (c) optional one or more dyes and/or one or more solvents.
In a particular embodiment, the light-emitting layer EML comprises (or essentially consists of) a composition comprising or consisting of:
(i) 1-50 % by weight, preferably 5-40 % by weight, in particular 10-30 % by weight, of one or more organic molecules according to the invention;
(ii) 5-99 % by weight, preferably 30-94.9 % by weight, in particular 40-89%
by weight, of at least one host compound H; and (iii) optionally 0-94 % by weight, preferably 0.1-65 % by weight, in particular 1-50 % by weight, of at least one further host compound D with a structure differing from the structure of the molecules according to the invention; and (iv) optionally 0-94 % by weight, preferably 0-65 % by weight, in particular 0-50 % by weight, of a solvent; and
In one embodiment, the light-emitting layer comprises not only the organic molecules according to the invention, but also a host material whose triplet (T1) and singlet (S1) energy levels are energetically higher than the triplet (T1) and singlet (S1) energy levels of the organic molecule.
A further aspect of the invention relates to a composition comprising or consisting of:
(a) at least one organic molecule according to the invention, in particular in the form of an emitter and/or a host, and (b) one or more emitter and/or host materials, which differ from the organic molecule according to the invention and (c) optional one or more dyes and/or one or more solvents.
In one embodiment, the light-emitting layer comprises (or essentially consists of) a composition comprising or consisting of:
(a) at least one organic molecule according to the invention, in particular in the form of an emitter and/or a host, and (b) one or more emitter and/or host materials, which differ from the organic molecule according to the invention and (c) optional one or more dyes and/or one or more solvents.
In a particular embodiment, the light-emitting layer EML comprises (or essentially consists of) a composition comprising or consisting of:
(i) 1-50 % by weight, preferably 5-40 % by weight, in particular 10-30 % by weight, of one or more organic molecules according to the invention;
(ii) 5-99 % by weight, preferably 30-94.9 % by weight, in particular 40-89%
by weight, of at least one host compound H; and (iii) optionally 0-94 % by weight, preferably 0.1-65 % by weight, in particular 1-50 % by weight, of at least one further host compound D with a structure differing from the structure of the molecules according to the invention; and (iv) optionally 0-94 % by weight, preferably 0-65 % by weight, in particular 0-50 % by weight, of a solvent; and
14 (v) optionally 0-30 % by weight, in particular 0-20 % by weight, preferably 0-5 % by weight, of at least one further emitter molecule F with a structure differing from the structure of the molecules according to the invention.
Preferably, energy can be transferred from the host compound H to the one or more organic molecules according to the invention, in particular transferred from the first excited triplet state 11(H) of the host compound H to the first excited triplet state Ti (E) of the one or more organic molecules according to the invention E and/ or from the first excited singlet state Si (H) of the host compound H to the first excited singlet state S1 (E) of the one or more organic molecules according to the invention E.
In a further embodiment, the light-emitting layer EML comprises (or essentially consists of) a composition comprising or consisting of:
(i) 1-50 % by weight, preferably 5-40 % by weight, in particular 10-30 % by weight, of one organic molecule according to the invention;
(ii) 5-99 % by weight, preferably 30-94.9 % by weight, in particular 40-89%
by weight, of one host compound H; and (iii) optionally 0-941Y0 by weight, preferably 0.1-65 % by weight, in particular 1-50 % by weight, of at least one further host compound D with a structure differing from the structure of the molecules according to the invention; and (iv) optionally 0-94 % by weight, preferably 0-65 % by weight, in particular 0-50 % by weight, of a solvent; and (v) optionally 0-30 % by weight, in particular 0-20 % by weight, preferably 0-5 % by weight, of at least one further emitter molecule F with a structure differing from the structure of the molecules according to the invention.
In one embodiment, the host compound H has a highest occupied molecular orbital HOMO(H) having an energy EH m (H) in the range of from -5 to -6.5 eV and the at least one further host compound D has a highest occupied molecular orbital HOMO(D) having an energy E"cm(D), wherein EHOMO(H) > EHOMO(D).
In a further embodiment, the host compound H has a lowest unoccupied molecular orbital LUMO(H) having an energy Eium (H) and the at least one further host compound D
has a lowest unoccupied molecular orbital LUMO(D) having an energy Ewmc)(D), wherein ELumo(H) > ELumo(D).
Preferably, energy can be transferred from the host compound H to the one or more organic molecules according to the invention, in particular transferred from the first excited triplet state 11(H) of the host compound H to the first excited triplet state Ti (E) of the one or more organic molecules according to the invention E and/ or from the first excited singlet state Si (H) of the host compound H to the first excited singlet state S1 (E) of the one or more organic molecules according to the invention E.
In a further embodiment, the light-emitting layer EML comprises (or essentially consists of) a composition comprising or consisting of:
(i) 1-50 % by weight, preferably 5-40 % by weight, in particular 10-30 % by weight, of one organic molecule according to the invention;
(ii) 5-99 % by weight, preferably 30-94.9 % by weight, in particular 40-89%
by weight, of one host compound H; and (iii) optionally 0-941Y0 by weight, preferably 0.1-65 % by weight, in particular 1-50 % by weight, of at least one further host compound D with a structure differing from the structure of the molecules according to the invention; and (iv) optionally 0-94 % by weight, preferably 0-65 % by weight, in particular 0-50 % by weight, of a solvent; and (v) optionally 0-30 % by weight, in particular 0-20 % by weight, preferably 0-5 % by weight, of at least one further emitter molecule F with a structure differing from the structure of the molecules according to the invention.
In one embodiment, the host compound H has a highest occupied molecular orbital HOMO(H) having an energy EH m (H) in the range of from -5 to -6.5 eV and the at least one further host compound D has a highest occupied molecular orbital HOMO(D) having an energy E"cm(D), wherein EHOMO(H) > EHOMO(D).
In a further embodiment, the host compound H has a lowest unoccupied molecular orbital LUMO(H) having an energy Eium (H) and the at least one further host compound D
has a lowest unoccupied molecular orbital LUMO(D) having an energy Ewmc)(D), wherein ELumo(H) > ELumo(D).
15 In one embodiment, the host compound H has a highest occupied molecular orbital HOMO(H) having an energy EH m (H) and a lowest unoccupied molecular orbital LUMO(H) having an energy ELumo,H), and the at least one further host compound D has a highest occupied molecular orbital HOMO(D) having an energy EH m (D) and a lowest unoccupied molecular orbital LUMO(D) having an energy ELum (D), the organic molecule according to the invention E has a highest occupied molecular orbital HOMO(E) having an energy EH m (E) and a lowest unoccupied molecular orbital LUMO(E) having an energy ELum (E), wherein EHomo(H) > EHom (D) and the difference between the energy level of the highest occupied molecular orbital HOMO(E) of the organic molecule according to the invention E
(E" m (E)) and the energy level of the highest occupied molecular orbital HOMO(H) of the host compound H
(EKomo(H)) is between -0.5 eV and 0.5 eV, more preferably between -0.3 eV and 0.3 eV, even more preferably between -0.2 eV and 0.2 eV or even between -0.1 eV and 0.1 eV;
and ELumo(H) > Ewmo, kD) and the difference between the energy level of the lowest unoccupied molecular orbital LUMO(E) of the organic molecule according to the invention E
(Ewm (E)) and the lowest unoccupied molecular orbital LUMO(D) of the at least one further host compound D
(ELum (D)) is between -0.5 eV and 0.5 eV, more preferably between -0.3 eV and 0.3 eV, even more preferably between -0.2 eV and 0.2 eV or even between -0.1 eV and 0.1 eV.
In one embodiment of the invention the host compound D and/ or the host compound H is a thermally-activated delayed fluorescence (TADF)-material. TADF materials exhibit a LEST value, which corresponds to the energy difference between the first excited singlet state (Si) and the first excited triplet state (Ti), of less than 2500 cm-1. Preferably the TADF
material exhibits a AEsT value of less than 3000 cm-1, more preferably less than 1500 cm-1, even more preferably less than 1000 crn-1 or even less than 500 cm-1.
In one embodiment, the host compound D is a TADF material and the host compound H exhibits a LIEsT value of more than 2500 cm-1. In a particular embodiment, the host compound D is a TADF
material and the host compound H is selected from group consisting of CBP, mCP, mCBP, 943-(dibenzofuran-2-yl)phenyI]-9H-carbazole, 9-[3-(dibenzofuran-2-yl)phenyI]-9H-carbazole, 943-(dibenzothiophen-2-yl)phenyl]-9H-carbazole, 9-[3,5-bis(2-dibenzofuranyl)pheny1]-9H-carbazole and 9[3,5-bis(2-dibenzothiophenyl)pheny1]-9H-carbazole.
(E" m (E)) and the energy level of the highest occupied molecular orbital HOMO(H) of the host compound H
(EKomo(H)) is between -0.5 eV and 0.5 eV, more preferably between -0.3 eV and 0.3 eV, even more preferably between -0.2 eV and 0.2 eV or even between -0.1 eV and 0.1 eV;
and ELumo(H) > Ewmo, kD) and the difference between the energy level of the lowest unoccupied molecular orbital LUMO(E) of the organic molecule according to the invention E
(Ewm (E)) and the lowest unoccupied molecular orbital LUMO(D) of the at least one further host compound D
(ELum (D)) is between -0.5 eV and 0.5 eV, more preferably between -0.3 eV and 0.3 eV, even more preferably between -0.2 eV and 0.2 eV or even between -0.1 eV and 0.1 eV.
In one embodiment of the invention the host compound D and/ or the host compound H is a thermally-activated delayed fluorescence (TADF)-material. TADF materials exhibit a LEST value, which corresponds to the energy difference between the first excited singlet state (Si) and the first excited triplet state (Ti), of less than 2500 cm-1. Preferably the TADF
material exhibits a AEsT value of less than 3000 cm-1, more preferably less than 1500 cm-1, even more preferably less than 1000 crn-1 or even less than 500 cm-1.
In one embodiment, the host compound D is a TADF material and the host compound H exhibits a LIEsT value of more than 2500 cm-1. In a particular embodiment, the host compound D is a TADF
material and the host compound H is selected from group consisting of CBP, mCP, mCBP, 943-(dibenzofuran-2-yl)phenyI]-9H-carbazole, 9-[3-(dibenzofuran-2-yl)phenyI]-9H-carbazole, 943-(dibenzothiophen-2-yl)phenyl]-9H-carbazole, 9-[3,5-bis(2-dibenzofuranyl)pheny1]-9H-carbazole and 9[3,5-bis(2-dibenzothiophenyl)pheny1]-9H-carbazole.
16 In one embodiment, the host compound H is a TADF material and the host compound D exhibits a LEST value of more than 2500 cm-1. In a particular embodiment, the host compound H is a TADF
material and the host compound D is selected from group consisting of T2T
(2,4,6-tris(bipheny1-3-y1)-1,3,5-triazine), T3T (2,4,6-tris(tripheny1-3-y1)-1,3,5-triazine) and/or TST (2,4,6-tris(9,9'-spirobifluorene-2-y1)-1,3,5-triazine).
In a further aspect, the invention relates to an optoelectronic device comprising an organic molecule or a composition of the type described here, more particularly in the form of a device selected from the group consisting of organic light-emitting diode (OLED), light-emitting electrochemical cell, OLED sensor, more particularly gas and vapour sensors not hermetically externally shielded, organic diode, organic solar cell, organic transistor, organic field-effect transistor, organic laser and down-conversion element.
In a preferred embodiment, the organic electroluminescent device is a device selected from the group consisting of an organic light emitting diode (OLED), a light emitting electrochemical cell (LEC), and a light-emitting transistor.
In one embodiment of the optoelectronic device of the invention, the organic molecule according to the invention E is used as emission material in a light-emitting layer EML.
In one embodiment of the optoelectronic device of the invention, the light-emitting layer EML
consists of the composition according to the invention described here.
When the organic electroluminescent device is an OLED, it may, for example, have the following layer structure:
1. substrate 2. anode layer A
3. hole injection layer, HIL
4. hole transport layer, HTL
5. electron blocking layer, EBL
6. emitting layer, EML
7. hole blocking layer, HBL
8. electron transport layer, ETL
9. electron injection layer, EIL
10. cathode layer,
material and the host compound D is selected from group consisting of T2T
(2,4,6-tris(bipheny1-3-y1)-1,3,5-triazine), T3T (2,4,6-tris(tripheny1-3-y1)-1,3,5-triazine) and/or TST (2,4,6-tris(9,9'-spirobifluorene-2-y1)-1,3,5-triazine).
In a further aspect, the invention relates to an optoelectronic device comprising an organic molecule or a composition of the type described here, more particularly in the form of a device selected from the group consisting of organic light-emitting diode (OLED), light-emitting electrochemical cell, OLED sensor, more particularly gas and vapour sensors not hermetically externally shielded, organic diode, organic solar cell, organic transistor, organic field-effect transistor, organic laser and down-conversion element.
In a preferred embodiment, the organic electroluminescent device is a device selected from the group consisting of an organic light emitting diode (OLED), a light emitting electrochemical cell (LEC), and a light-emitting transistor.
In one embodiment of the optoelectronic device of the invention, the organic molecule according to the invention E is used as emission material in a light-emitting layer EML.
In one embodiment of the optoelectronic device of the invention, the light-emitting layer EML
consists of the composition according to the invention described here.
When the organic electroluminescent device is an OLED, it may, for example, have the following layer structure:
1. substrate 2. anode layer A
3. hole injection layer, HIL
4. hole transport layer, HTL
5. electron blocking layer, EBL
6. emitting layer, EML
7. hole blocking layer, HBL
8. electron transport layer, ETL
9. electron injection layer, EIL
10. cathode layer,
17 wherein the OLED comprises each layer selected from the group of HIL, HTL, EBL, HBL, ETL, and EIL only optionally, different layers may be merged and the OLED may comprise more than one layer of each layer type defined above.
Furthermore, the organic electroluminescent device may, in one embodiment, comprise one or more protective layers protecting the device from damaging exposure to harmful species in the environment including, for example, moisture, vapor and/or gases.
In one embodiment of the invention, the organic electroluminescent device is an OLED, with the following inverted layer structure:
1. substrate 2. cathode layer 3. electron injection layer, EIL
4. electron transport layer, ETL
5. hole blocking layer, HBL
6. emitting layer, B
7. electron blocking layer, EBL
8. hole transport layer, HTL
9. hole injection layer, HIL
10. anode layer A
wherein the OLED comprises each layer selected from the group of HIL, HTL, EBL, HBL, ETL, and EIL only optionally, different layers may be merged and the OLED may comprise more than one layer of each layer types defined above.
In one embodiment of the invention, the organic electroluminescent device is an OLED, which may have a stacked architecture. In this architecture, contrary to the typical arrangement in which the OLEDs are placed side by side, the individual units are stacked on top of each other. Blended light may be generated with OLEDs exhibiting a stacked architecture, in particular white light may be generated by stacking blue, green and red OLEDs. Furthermore, the OLED
exhibiting a stacked architecture may comprise a charge generation layer (CGL), which is typically located between two OLED subunits and typically consists of a n-doped and p-doped layer with the n-doped layer of one CGL being typically located closer to the anode layer.
Furthermore, the organic electroluminescent device may, in one embodiment, comprise one or more protective layers protecting the device from damaging exposure to harmful species in the environment including, for example, moisture, vapor and/or gases.
In one embodiment of the invention, the organic electroluminescent device is an OLED, with the following inverted layer structure:
1. substrate 2. cathode layer 3. electron injection layer, EIL
4. electron transport layer, ETL
5. hole blocking layer, HBL
6. emitting layer, B
7. electron blocking layer, EBL
8. hole transport layer, HTL
9. hole injection layer, HIL
10. anode layer A
wherein the OLED comprises each layer selected from the group of HIL, HTL, EBL, HBL, ETL, and EIL only optionally, different layers may be merged and the OLED may comprise more than one layer of each layer types defined above.
In one embodiment of the invention, the organic electroluminescent device is an OLED, which may have a stacked architecture. In this architecture, contrary to the typical arrangement in which the OLEDs are placed side by side, the individual units are stacked on top of each other. Blended light may be generated with OLEDs exhibiting a stacked architecture, in particular white light may be generated by stacking blue, green and red OLEDs. Furthermore, the OLED
exhibiting a stacked architecture may comprise a charge generation layer (CGL), which is typically located between two OLED subunits and typically consists of a n-doped and p-doped layer with the n-doped layer of one CGL being typically located closer to the anode layer.
18 In one embodiment of the invention, the organic electroluminescent device is an OLED, which comprises two or more emission layers between anode and cathode. In particular, this so-called tandem OLED comprises three emission layers, wherein one emission layer emits red light, one emission layer emits green light and one emission layer emits blue light, and optionally may comprise further layers such as charge generation layers, blocking or transporting layers between the individual emission layers. In a further embodiment, the emission layers are adjacently stacked. In a further embodiment, the tandem OLED comprises a charge generation layer between each two emission layers. In addition, adjacent emission layers or emission layers separated by a charge generation layer may be merged.
The substrate may be formed by any material or composition of materials. Most frequently, glass slides are used as substrates. Alternatively, thin metal layers (e.g., copper, gold, silver or aluminum films) or plastic films or slides may be used. This may allow for a higher degree of flexibility. The anode layer A is mostly composed of materials allowing to obtain an (essentially) transparent film. As at least one of both electrodes should be (essentially) transparent in order to allow light emission from the OLED, either the anode layer A or the cathode layer C is transparent.
Preferably, the anode layer A comprises a large content or even consists of transparent conductive oxides (TC0s). Such anode layer A may, for example, comprise indium tin oxide, aluminum zinc oxide, fluorine doped tin oxide, indium zinc oxide, Pb0, SnO, zirconium oxide, molybdenum oxide, vanadium oxide, tungsten oxide, graphite, doped Si, doped Ge, doped GaAs, doped polyaniline, doped polypyrrol and/or doped polythiophene.
The anode layer A (essentially) may consist of indium tin oxide (ITO) (e.g., (In03)0.5(Sn02)0.1). The roughness of the anode layer A caused by the transparent conductive oxides (TC0s) may be compensated by using a hole injection layer (HIL). Further, the HIL may facilitate the injection of quasi charge carriers (i.e., holes) in that the transport of the quasi charge carriers from the TCO
to the hole transport layer (HTL) is facilitated. The hole injection layer (HIL) may comprise poly-3,4-ethylendioxy thiophene (PEDOT), polystyrene sulfonate (PSS), Mo02, V205, CuPC or Cul, in particular a mixture of PEDOT and PSS. The hole injection layer (HIL) may also prevent the diffusion of metals from the anode layer A into the hole transport layer (HTL). The HIL may exemplarily comprise PEDOT:PSS (poly-3,4-ethylendioxy thiophene: polystyrene sulfonate), PEDOT (poly-3,4-ethylendioxy thiophene), mMTDATA (4,4',4"-tris[phenyl(m-tolyl)amino]triphenylamine), Spiro-TAD .. (2,2',7,7'-tetrakis(n,n-diphenylamino)-9,9'-spirobifluorene), DNTPD (Ni ,N11-(biphenyl-4,4'-diyObis(N1-phenyl-N4,N4-di-m-tolylbenzene-1 ,4-
The substrate may be formed by any material or composition of materials. Most frequently, glass slides are used as substrates. Alternatively, thin metal layers (e.g., copper, gold, silver or aluminum films) or plastic films or slides may be used. This may allow for a higher degree of flexibility. The anode layer A is mostly composed of materials allowing to obtain an (essentially) transparent film. As at least one of both electrodes should be (essentially) transparent in order to allow light emission from the OLED, either the anode layer A or the cathode layer C is transparent.
Preferably, the anode layer A comprises a large content or even consists of transparent conductive oxides (TC0s). Such anode layer A may, for example, comprise indium tin oxide, aluminum zinc oxide, fluorine doped tin oxide, indium zinc oxide, Pb0, SnO, zirconium oxide, molybdenum oxide, vanadium oxide, tungsten oxide, graphite, doped Si, doped Ge, doped GaAs, doped polyaniline, doped polypyrrol and/or doped polythiophene.
The anode layer A (essentially) may consist of indium tin oxide (ITO) (e.g., (In03)0.5(Sn02)0.1). The roughness of the anode layer A caused by the transparent conductive oxides (TC0s) may be compensated by using a hole injection layer (HIL). Further, the HIL may facilitate the injection of quasi charge carriers (i.e., holes) in that the transport of the quasi charge carriers from the TCO
to the hole transport layer (HTL) is facilitated. The hole injection layer (HIL) may comprise poly-3,4-ethylendioxy thiophene (PEDOT), polystyrene sulfonate (PSS), Mo02, V205, CuPC or Cul, in particular a mixture of PEDOT and PSS. The hole injection layer (HIL) may also prevent the diffusion of metals from the anode layer A into the hole transport layer (HTL). The HIL may exemplarily comprise PEDOT:PSS (poly-3,4-ethylendioxy thiophene: polystyrene sulfonate), PEDOT (poly-3,4-ethylendioxy thiophene), mMTDATA (4,4',4"-tris[phenyl(m-tolyl)amino]triphenylamine), Spiro-TAD .. (2,2',7,7'-tetrakis(n,n-diphenylamino)-9,9'-spirobifluorene), DNTPD (Ni ,N11-(biphenyl-4,4'-diyObis(N1-phenyl-N4,N4-di-m-tolylbenzene-1 ,4-
19 diamine), NPB (N,N'-nis-(1-naphthaleny1)-N,N'-bis-phenyl-(1,1'-bipheny1)-4,4'-diamine), NPNPB
(N,N'-diphenyl-N,N'-di-[4-(N,N-diphenyl-amino)phenyl]benzidine), Me0-TPD (N, N, N',Ni-tetrakis(4-methoxyphenyl)benzid ine), HAT-CN (1,4,5,8,9,11-hexaazatriphenylen-hexacarbonitrile) and/or Spiro-NPD (N,N'-diphenyl-N,N'-bis-(1-naphthyl)-9,9'-spirobifluorene-2,7-diamine).
Adjacent to the anode layer A or hole injection layer (H IL), a hole transport layer (HTL) is typically located. Herein, any hole transport compound may be used. For example, electron-rich heteroaromatic compounds such as triarylamines and/or carbazoles may be used as hole transport compound. The HTL may decrease the energy barrier between the anode layer A and the light-emitting layer EML. The hole transport layer (HTL) may also be an electron blocking layer (EBL). Preferably, hole transport compounds bear comparably high energy levels of their triplet states TI. For example, the hole transport layer (HTL) may comprise a star-shaped heterocycle such as tris(4-carbazoy1-9-ylphenyl)amine (TCTA), poly-TPD (poly(4-butylphenyl-diphenyl-amine)), [alphaj-NPD (poly(4-butylphenyl-diphenyl-amine)), TAPC (4,4'-cyclohexyliden-bis[N,N-bis(4-methylphenyl)benzenamine]), 2-TNATA
(4,4',4"-tris[2-naphthyl(phenypamino]triphenylamine), Spiro-TAD, DNTPD, NPB, NPNPB, Me0-TPD, HAT-CN
and/or TrisPcz (9,9'-dipheny1-6-(9-phenyl-9H-carbazol-3-y1)-9H,91H-3,3'-bicarbazole). In addition, the HTL may comprise a p-doped layer, which may be composed of an inorganic or organic dopant in an organic hole-transporting matrix. Transition metal oxides such as vanadium oxide, molybdenum oxide or tungsten oxide may exemplarily be used as inorganic dopant.
Tetrafluorotetracyanoquinodimethane (F4-TCNQ), copper-pentafluorobenzoate (Cu(l)pFBz) or transition metal complexes may exemplarily be used as organic dopant.
The EBL may exemplarily comprise mCP (1,3-bis(carbazol-9-yl)benzene), TCTA, 2-TNATA, mCBP (3,3-di(9H-carbazol-9-yl)biphenyl), tris-Pcz, CzSi (9-(4-tert-ButylphenyI)-3,6-bis(triphenylsily1)-9H-carbazole), and/or DCB (N,N'-dicarbazoly1-1,4-dimethylbenzene).
Adjacent to the hole transport layer (HTL), the light-emitting layer EML is typically located. The light-emitting layer EML comprises at least one light emitting molecule.
Particularly, the EML
comprises at least one light emitting molecule according to the invention E.
In one embodiment, the light-emitting layer comprises only the organic molecules according to the invention. Typically, the EML additionally comprises one or more host materials H. Exemplarily, the host material H is selected from CBP (4,4'-Bis-(N-carbazolyI)-biphenyl), mCP, mCBP Sif87 (dibenzo[b,d]thiophen-2-yltriphenylsilane), CzSi, Sif88 (dibenzo[b,d]thiophen-2-yl)diphenylsilane), DPEPO (bis[2-
(N,N'-diphenyl-N,N'-di-[4-(N,N-diphenyl-amino)phenyl]benzidine), Me0-TPD (N, N, N',Ni-tetrakis(4-methoxyphenyl)benzid ine), HAT-CN (1,4,5,8,9,11-hexaazatriphenylen-hexacarbonitrile) and/or Spiro-NPD (N,N'-diphenyl-N,N'-bis-(1-naphthyl)-9,9'-spirobifluorene-2,7-diamine).
Adjacent to the anode layer A or hole injection layer (H IL), a hole transport layer (HTL) is typically located. Herein, any hole transport compound may be used. For example, electron-rich heteroaromatic compounds such as triarylamines and/or carbazoles may be used as hole transport compound. The HTL may decrease the energy barrier between the anode layer A and the light-emitting layer EML. The hole transport layer (HTL) may also be an electron blocking layer (EBL). Preferably, hole transport compounds bear comparably high energy levels of their triplet states TI. For example, the hole transport layer (HTL) may comprise a star-shaped heterocycle such as tris(4-carbazoy1-9-ylphenyl)amine (TCTA), poly-TPD (poly(4-butylphenyl-diphenyl-amine)), [alphaj-NPD (poly(4-butylphenyl-diphenyl-amine)), TAPC (4,4'-cyclohexyliden-bis[N,N-bis(4-methylphenyl)benzenamine]), 2-TNATA
(4,4',4"-tris[2-naphthyl(phenypamino]triphenylamine), Spiro-TAD, DNTPD, NPB, NPNPB, Me0-TPD, HAT-CN
and/or TrisPcz (9,9'-dipheny1-6-(9-phenyl-9H-carbazol-3-y1)-9H,91H-3,3'-bicarbazole). In addition, the HTL may comprise a p-doped layer, which may be composed of an inorganic or organic dopant in an organic hole-transporting matrix. Transition metal oxides such as vanadium oxide, molybdenum oxide or tungsten oxide may exemplarily be used as inorganic dopant.
Tetrafluorotetracyanoquinodimethane (F4-TCNQ), copper-pentafluorobenzoate (Cu(l)pFBz) or transition metal complexes may exemplarily be used as organic dopant.
The EBL may exemplarily comprise mCP (1,3-bis(carbazol-9-yl)benzene), TCTA, 2-TNATA, mCBP (3,3-di(9H-carbazol-9-yl)biphenyl), tris-Pcz, CzSi (9-(4-tert-ButylphenyI)-3,6-bis(triphenylsily1)-9H-carbazole), and/or DCB (N,N'-dicarbazoly1-1,4-dimethylbenzene).
Adjacent to the hole transport layer (HTL), the light-emitting layer EML is typically located. The light-emitting layer EML comprises at least one light emitting molecule.
Particularly, the EML
comprises at least one light emitting molecule according to the invention E.
In one embodiment, the light-emitting layer comprises only the organic molecules according to the invention. Typically, the EML additionally comprises one or more host materials H. Exemplarily, the host material H is selected from CBP (4,4'-Bis-(N-carbazolyI)-biphenyl), mCP, mCBP Sif87 (dibenzo[b,d]thiophen-2-yltriphenylsilane), CzSi, Sif88 (dibenzo[b,d]thiophen-2-yl)diphenylsilane), DPEPO (bis[2-
20 (diphenylphosphino)phenyl] ether oxide), 9[3-(dibenzofuran-2-yl)pheny1]-9H-carbazole, 9-[3-(dibenzofuran-2-yl)pheny1]-9H-carbazole, 9[3-(dibenzothiophen-2-yl)pheny1]-9H-carbazole, 9-[3,5-bis(2-dibenzofu ranyl)phenyl]-9 H-carbazole, 943 ,5-bis(2-dibenzoth iophenyl)pheny1]-9H-carbazole, T2T (2,4,6-tris(bipheny1-3-y1)-1,3,5-triazine), T3T (2,4,6-tris(tripheny1-3-y1)-1,3,5-triazine) and/or TST (2,4,6-tris(9,9'-spirobifluorene-2-yI)-1,3,5-triazine).
The host material H
typically should be selected to exhibit first triplet (T1) and first singlet (S1) energy levels, which are energetically higher than the first triplet (T1) and first singlet (Si) energy levels of the organic molecule.
In one embodiment of the invention, the EML comprises a so-called mixed-host system with at least one hole-dominant host and one electron-dominant host. In a particular embodiment, the EML comprises exactly one light emitting organic molecule according to the invention and a mixed-host system comprising T2T as electron-dominant host and a host selected from CBP, mCP, mCBP, 9[3-(dibenzofuran-2-yl)phenylj-9H-carbazole, 943-(dibenzofuran-2-yl)pheny1]-9H-carbazole, 9[3-(dibenzothiophen-2-yl)pheny1]-9H-carbazole, 9-[3,5-bis(2-dibenzofuranyl)pheny1]-9H-carbazole and 9[3,5-bis(2-dibenzothiophenyl)pheny11-9H-carbazole as hole-dominant host. In a further embodiment the EML comprises 50-80 % by weight, preferably 60-75 % by weight of a host selected from CBP, mCP, mCBP, 943-(dibenzofuran-2-Aphenyl]-9H-carbazole, 9[3-(dibenzofuran-2-yl)pheny1]-9H-carbazole, 943-(dibenzothiophen-2-yl)pheny1]-9 H-carbazole, 943,5-bis(2-dibenzofuranyl)pheny1]-9H-carbazole and 943,5-bis(2-dibenzothiophenyl)pheny1]-9H-carbazole; 10-45 % by weight, preferably 15-30 %
by weight of T2T and 5-40 % by weight, preferably 10-30 % by weight of light emitting molecule according to the invention.
Adjacent to the light-emitting layer EML, an electron transport layer (ETL) may be located. Herein, any electron transporter may be used. Exemplarily, electron-poor compounds such as, e.g., benzimidazoles, pyridines, triazoles, oxadiazoles (e.g., 1,3,4-oxadiazole), phosphinoxides and sulfone, may be used. An electron transporter may also be a star-shaped heterocycle such as 1,3,5-tri(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl (TPBi). The ETL may comprise NBphen (2,9-bis(naphthalen-2-y1)-4,7-dipheny1-1,10-phenanthroline), Alq3 (Aluminum-tris(8-hydroxyquinoline)), TSPO1 (dipheny1-4-triphenylsilylphenyl-phosphinoxide), BPyTP2 (2,7-di(2,21-bipyridin-5-yl)triphenyle), Sif87 (dibenzo[b,d]thiophen-2-yltriphenylsilane), Sif88 (dibenzo[b,d]thiophen-2-yOdiphenylsilane), BmPyPhB (1,3-bis[3,5-di(pyridin-3-yl)phenyl]benzene) and/or BTB (4,4'-bis42-(4,6-dipheny1-1,3,5-triazinyl)]-1,1'-biphenyl).
The host material H
typically should be selected to exhibit first triplet (T1) and first singlet (S1) energy levels, which are energetically higher than the first triplet (T1) and first singlet (Si) energy levels of the organic molecule.
In one embodiment of the invention, the EML comprises a so-called mixed-host system with at least one hole-dominant host and one electron-dominant host. In a particular embodiment, the EML comprises exactly one light emitting organic molecule according to the invention and a mixed-host system comprising T2T as electron-dominant host and a host selected from CBP, mCP, mCBP, 9[3-(dibenzofuran-2-yl)phenylj-9H-carbazole, 943-(dibenzofuran-2-yl)pheny1]-9H-carbazole, 9[3-(dibenzothiophen-2-yl)pheny1]-9H-carbazole, 9-[3,5-bis(2-dibenzofuranyl)pheny1]-9H-carbazole and 9[3,5-bis(2-dibenzothiophenyl)pheny11-9H-carbazole as hole-dominant host. In a further embodiment the EML comprises 50-80 % by weight, preferably 60-75 % by weight of a host selected from CBP, mCP, mCBP, 943-(dibenzofuran-2-Aphenyl]-9H-carbazole, 9[3-(dibenzofuran-2-yl)pheny1]-9H-carbazole, 943-(dibenzothiophen-2-yl)pheny1]-9 H-carbazole, 943,5-bis(2-dibenzofuranyl)pheny1]-9H-carbazole and 943,5-bis(2-dibenzothiophenyl)pheny1]-9H-carbazole; 10-45 % by weight, preferably 15-30 %
by weight of T2T and 5-40 % by weight, preferably 10-30 % by weight of light emitting molecule according to the invention.
Adjacent to the light-emitting layer EML, an electron transport layer (ETL) may be located. Herein, any electron transporter may be used. Exemplarily, electron-poor compounds such as, e.g., benzimidazoles, pyridines, triazoles, oxadiazoles (e.g., 1,3,4-oxadiazole), phosphinoxides and sulfone, may be used. An electron transporter may also be a star-shaped heterocycle such as 1,3,5-tri(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl (TPBi). The ETL may comprise NBphen (2,9-bis(naphthalen-2-y1)-4,7-dipheny1-1,10-phenanthroline), Alq3 (Aluminum-tris(8-hydroxyquinoline)), TSPO1 (dipheny1-4-triphenylsilylphenyl-phosphinoxide), BPyTP2 (2,7-di(2,21-bipyridin-5-yl)triphenyle), Sif87 (dibenzo[b,d]thiophen-2-yltriphenylsilane), Sif88 (dibenzo[b,d]thiophen-2-yOdiphenylsilane), BmPyPhB (1,3-bis[3,5-di(pyridin-3-yl)phenyl]benzene) and/or BTB (4,4'-bis42-(4,6-dipheny1-1,3,5-triazinyl)]-1,1'-biphenyl).
21 Optionally, the ETL may be doped with materials such as Liq. The electron transport layer (ETL) may also block holes or a holeblocking layer (HBL) is introduced.
The HBL may, for example, comprise BCP (2,9-dimethy1-4,7-dipheny1-1,10-phenanthroline =
Bathocuproine), BAlq (bis(8-hydroxy-2-methylquinoline)-(4-phenylphenoxy)aluminum), NBphen (2,9-bis(naphthalen-2-y1)-4,7-dipheny1-1 ,10-phenanthroline), Alq3 (Aluminum-tris(8-hydroxyquinoline)), TSPO1 (dipheny1-4-triphenylsilylphenyl-phosphinoxide), T2T
(2,4,6-tris(bipheny1-3-y1)-1 ,3,5-triazine), T3T (2,4,6-tris(tripheny1-3-y1)-1,3,5-triazine), TST (2,4,6-tris(9,9'-spirobifluorene-2-y1)-1,3,5-triazine), and/or TCBTTCP (1,3,5-tris(N-carbazolyl)benzol/
1,3,5-tris(carbazol)-9-y1) benzene).
Adjacent to the electron transport layer (ETL), a cathode layer C may be located.The cathode layer C may, for example, comprise or may consist of a metal (e.g., Al, Au, Ag, Pt, Cu, Zn, Ni, Fe, Pb, LiF, Ca, Ba, Mg, In, W, or Pd) or a metal alloy. For practical reasons, the cathode layer may also consist of (essentially) intransparent metals such as Mg, Ca or Al.
Alternatively or additionally, the cathode layer C may also comprise graphite and or carbon nanotubes (CNTs).
Alternatively, the cathode layer C may also consist of nanoscalic silver wires.
An OLED may further, optionally, comprise a protection layer between the electron transport layer (ETL) and the cathode layer C (which may be designated as electron injection layer (EIL)). This layer may comprise lithium fluoride, cesium fluoride, silver, Liq (8-hydroxyquinolinolatolithium), Li2O, BaF2, MgO and/or NaF.
Optionally, the electron transport layer (ETL) and/or a hole blocking layer (HBL) may also comprise one or more host compounds H.
In order to modify the emission spectrum and/or the absorption spectrum of the light-emitting layer EML further, the light-emitting layer EML may further comprise one or more further emitter molecules F. Such an emitter molecule F may be any emitter molecule known in the art. Preferably such an emitter molecule F is a molecule with a structure differing from the structure of the molecules according to the invention E. The emitter molecule F may optionally be a TADF emitter.
Alternatively, the emitter molecule F may optionally be a fluorescent and/or phosphorescent emitter molecule which is able to shift the emission spectrum and/or the absorption spectrum of the light-emitting layer EML. Exemplarily, the triplet and/or singlet excitons may be transferred from the organic emitter molecule according to the invention to the emitter molecule F before relaxing to the ground state SO by emitting light typically red-shifted in comparison to the light
The HBL may, for example, comprise BCP (2,9-dimethy1-4,7-dipheny1-1,10-phenanthroline =
Bathocuproine), BAlq (bis(8-hydroxy-2-methylquinoline)-(4-phenylphenoxy)aluminum), NBphen (2,9-bis(naphthalen-2-y1)-4,7-dipheny1-1 ,10-phenanthroline), Alq3 (Aluminum-tris(8-hydroxyquinoline)), TSPO1 (dipheny1-4-triphenylsilylphenyl-phosphinoxide), T2T
(2,4,6-tris(bipheny1-3-y1)-1 ,3,5-triazine), T3T (2,4,6-tris(tripheny1-3-y1)-1,3,5-triazine), TST (2,4,6-tris(9,9'-spirobifluorene-2-y1)-1,3,5-triazine), and/or TCBTTCP (1,3,5-tris(N-carbazolyl)benzol/
1,3,5-tris(carbazol)-9-y1) benzene).
Adjacent to the electron transport layer (ETL), a cathode layer C may be located.The cathode layer C may, for example, comprise or may consist of a metal (e.g., Al, Au, Ag, Pt, Cu, Zn, Ni, Fe, Pb, LiF, Ca, Ba, Mg, In, W, or Pd) or a metal alloy. For practical reasons, the cathode layer may also consist of (essentially) intransparent metals such as Mg, Ca or Al.
Alternatively or additionally, the cathode layer C may also comprise graphite and or carbon nanotubes (CNTs).
Alternatively, the cathode layer C may also consist of nanoscalic silver wires.
An OLED may further, optionally, comprise a protection layer between the electron transport layer (ETL) and the cathode layer C (which may be designated as electron injection layer (EIL)). This layer may comprise lithium fluoride, cesium fluoride, silver, Liq (8-hydroxyquinolinolatolithium), Li2O, BaF2, MgO and/or NaF.
Optionally, the electron transport layer (ETL) and/or a hole blocking layer (HBL) may also comprise one or more host compounds H.
In order to modify the emission spectrum and/or the absorption spectrum of the light-emitting layer EML further, the light-emitting layer EML may further comprise one or more further emitter molecules F. Such an emitter molecule F may be any emitter molecule known in the art. Preferably such an emitter molecule F is a molecule with a structure differing from the structure of the molecules according to the invention E. The emitter molecule F may optionally be a TADF emitter.
Alternatively, the emitter molecule F may optionally be a fluorescent and/or phosphorescent emitter molecule which is able to shift the emission spectrum and/or the absorption spectrum of the light-emitting layer EML. Exemplarily, the triplet and/or singlet excitons may be transferred from the organic emitter molecule according to the invention to the emitter molecule F before relaxing to the ground state SO by emitting light typically red-shifted in comparison to the light
22 emitted by an organic molecule. Optionally, the emitter molecule F may also provoke two-photon effects (i.e., the absorption of two photons of half the energy of the absorption maximum).
Optionally, an organic electroluminescent device (e.g., an OLED) may, for example, be an essentially white organic electroluminescent device. Exemplarily such white organic electroluminescent device may comprise at least one (deep) blue emitter molecule and one or more emitter molecules emitting green and/or red light. Then, there may also optionally be energy transmittance between two or more molecules as described above.
As used herein, if not defined more specifically in the particular context, the designation of the colors of emitted and/or absorbed light is as follows:
violet: wavelength range of >380-420 nm;
deep blue: wavelength range of >420-480 nm;
sky blue: wavelength range of >480-500 nm;
green: wavelength range of >500-560 nm;
yellow: wavelength range of >560-580 nm;
orange: wavelength range of >580-620 nm;
red: wavelength range of >620-800 nm.
With respect to emitter molecules, such colors refer to the emission maximum.
Therefore, exemplarily, a deep blue emitter has an emission maximum in the range of from >420 to 480 nm, a sky blue emitter has an emission maximum in the range of from >480 to 500 nm, a green emitter has an emission maximum in a range of from >500 to 560 nm, a red emitter has an emission maximum in a range of from >620 to 800 nm.
A deep blue emitter may preferably have an emission maximum of below 480 nm, more preferably below 470 nm, even more preferably below 465 nm or even below 460 nm. It will typically be above 420 nm, preferably above 430 nm, more preferably above 440 nm or even above 450 nm.
Accordingly, a further aspect of the present invention relates to an OLED, which exhibits an external quantum efficiency at 1000 cd/m2 of more than 8 %, more preferably of more than 10 %, more preferably of more than 13 %, even more preferably of more than 15 % or even more than 20 % and/or exhibits an emission maximum between 420 nm and 500 nm, preferably between 430 nm and 490 nm, more preferably between 440 nm and 480 nm, even more preferably between 450 nm and 470 nm and/or exhibits a LT80 value at 500 cd/m2 of more than 100 h,
Optionally, an organic electroluminescent device (e.g., an OLED) may, for example, be an essentially white organic electroluminescent device. Exemplarily such white organic electroluminescent device may comprise at least one (deep) blue emitter molecule and one or more emitter molecules emitting green and/or red light. Then, there may also optionally be energy transmittance between two or more molecules as described above.
As used herein, if not defined more specifically in the particular context, the designation of the colors of emitted and/or absorbed light is as follows:
violet: wavelength range of >380-420 nm;
deep blue: wavelength range of >420-480 nm;
sky blue: wavelength range of >480-500 nm;
green: wavelength range of >500-560 nm;
yellow: wavelength range of >560-580 nm;
orange: wavelength range of >580-620 nm;
red: wavelength range of >620-800 nm.
With respect to emitter molecules, such colors refer to the emission maximum.
Therefore, exemplarily, a deep blue emitter has an emission maximum in the range of from >420 to 480 nm, a sky blue emitter has an emission maximum in the range of from >480 to 500 nm, a green emitter has an emission maximum in a range of from >500 to 560 nm, a red emitter has an emission maximum in a range of from >620 to 800 nm.
A deep blue emitter may preferably have an emission maximum of below 480 nm, more preferably below 470 nm, even more preferably below 465 nm or even below 460 nm. It will typically be above 420 nm, preferably above 430 nm, more preferably above 440 nm or even above 450 nm.
Accordingly, a further aspect of the present invention relates to an OLED, which exhibits an external quantum efficiency at 1000 cd/m2 of more than 8 %, more preferably of more than 10 %, more preferably of more than 13 %, even more preferably of more than 15 % or even more than 20 % and/or exhibits an emission maximum between 420 nm and 500 nm, preferably between 430 nm and 490 nm, more preferably between 440 nm and 480 nm, even more preferably between 450 nm and 470 nm and/or exhibits a LT80 value at 500 cd/m2 of more than 100 h,
23 preferably more than 200 h, more preferably more than 400 h, even more preferably more than 750 h or even more than 1000 h. Accordingly, a further aspect of the present invention relates to an OLED, whose emission exhibits a ClEy color coordinate of less than 0.45, preferably less than 0.30, more preferably less than 0.20 or even more preferably less than 0.15 or even less than 0.10.
A further aspect of the present invention relates to an OLED, which emits light at a distinct color point. According to the present invention, the OLED emits light with a narrow emission band (small full width at half maximum (FWHM)). In one aspect, the OLED according to the invention emits light with a FWHM of the main emission peak of less than 0.40 eV, preferably less than 0.35 eV, more preferably less than 0.33 eV, even more preferably less than 0.30 eV or even less than 0.28 eV.
A further aspect of the present invention relates to an OLED, which emits light with ClEx and ClEy color coordinates close to the ClEx (= 0.131) and ClEy (= 0.046) color coordinates of the primary color blue (ClEx = 0.131 and ClEy = 0.046) as defined by ITU-R Recommendation BT.2020 (Rec.
2020) and thus is suited for the use in Ultra High Definition (UHD) displays, e.g. UHD-TVs.
Accordingly, a further aspect of the present invention relates to an OLED, whose emission exhibits a ClEx color coordinate of between 0.02 and 0.30, preferably between 0.03 and 0.25, more preferably between 0.05 and 0.20 or even more preferably between 0.08 and 0.18 or even between 0.10 and 0.15 and/ or a ClEy color coordinate of between 0.00 and 0.45, preferably between 0.01 and 0.30, more preferably between 0.02 and 0.20 or even more preferably between 0.03 and 0.15 or even between 0.04 and 0.10.
In a further aspect, the invention relates to a method for producing an optoelectronic component.
In this case an organic molecule of the invention is used.
The organic electroluminescent device, in particular the OLED according to the present invention can be fabricated by any means of vapor deposition and/ or liquid processing.
Accordingly, at least one layer is prepared by means of a sublimation process, prepared by means of an organic vapor phase deposition process, prepared by means of a carrier gas sublimation process, solution processed or printed.
A further aspect of the present invention relates to an OLED, which emits light at a distinct color point. According to the present invention, the OLED emits light with a narrow emission band (small full width at half maximum (FWHM)). In one aspect, the OLED according to the invention emits light with a FWHM of the main emission peak of less than 0.40 eV, preferably less than 0.35 eV, more preferably less than 0.33 eV, even more preferably less than 0.30 eV or even less than 0.28 eV.
A further aspect of the present invention relates to an OLED, which emits light with ClEx and ClEy color coordinates close to the ClEx (= 0.131) and ClEy (= 0.046) color coordinates of the primary color blue (ClEx = 0.131 and ClEy = 0.046) as defined by ITU-R Recommendation BT.2020 (Rec.
2020) and thus is suited for the use in Ultra High Definition (UHD) displays, e.g. UHD-TVs.
Accordingly, a further aspect of the present invention relates to an OLED, whose emission exhibits a ClEx color coordinate of between 0.02 and 0.30, preferably between 0.03 and 0.25, more preferably between 0.05 and 0.20 or even more preferably between 0.08 and 0.18 or even between 0.10 and 0.15 and/ or a ClEy color coordinate of between 0.00 and 0.45, preferably between 0.01 and 0.30, more preferably between 0.02 and 0.20 or even more preferably between 0.03 and 0.15 or even between 0.04 and 0.10.
In a further aspect, the invention relates to a method for producing an optoelectronic component.
In this case an organic molecule of the invention is used.
The organic electroluminescent device, in particular the OLED according to the present invention can be fabricated by any means of vapor deposition and/ or liquid processing.
Accordingly, at least one layer is prepared by means of a sublimation process, prepared by means of an organic vapor phase deposition process, prepared by means of a carrier gas sublimation process, solution processed or printed.
24 The methods used to fabricate the organic electroluminescent device, in particular the OLED
according to the present invention are known in the art. The different layers are individually and successively deposited on a suitable substrate by means of subsequent deposition processes.
The individual layers may be deposited using the same or differing deposition methods.
Vapor deposition processes, for example, comprise thermal (co)evaporation, chemical vapor deposition and physical vapor deposition. For active matrix OLED display, an AMOLED backplane is used as substrate. The individual layer may be processed from solutions or dispersions employing adequate solvents. Solution deposition process exemplarily comprise spin coating, dip coating and jet printing. Liquid processing may optionally be carried out in an inert atmosphere (e.g., in a nitrogen atmosphere) and the solvent may optionally be completely or partially removed by means known in the state of the art.
Examples General synthesis scheme I
Rx Rix R" i Rxii Rx1 Rx' Rviii Rx Rxii \ / Rv" Br N N
N Br Rix N FF NaH Riv H CI +
El RVX ¨R2 dry toluene Rv 1 Rviii Rill Riv 120 C CI X CI
Rvl Rv"
R" ).<,R E3 E3 RI \N / Rvl N
H CI
E2 R" RI
RII Rxi Rill / \N
Ri Rxii N N tBuLi Ni j Riv Br Rix BBr3 THF Rv I
B R
NI,),,N Rviii d r '. 1 Rv I , dry -78 C Rvi N m / "i\ Rxii Rvi CI / X CI will RvIl R1 zi R2 Rviii RxI
Rix Rx General procedure for synthesis:
El (1.00 equivalent), E2 (1.00 equivalent) were dissolved in dry toluene under nitrogen atmosphere and cooled to 0 C in an ice-bath. NaH (1.05 equivalent) was added in small portions.
The reaction mixture was stirred at 0 C for 10 min. The ice-bath was then removed and the
according to the present invention are known in the art. The different layers are individually and successively deposited on a suitable substrate by means of subsequent deposition processes.
The individual layers may be deposited using the same or differing deposition methods.
Vapor deposition processes, for example, comprise thermal (co)evaporation, chemical vapor deposition and physical vapor deposition. For active matrix OLED display, an AMOLED backplane is used as substrate. The individual layer may be processed from solutions or dispersions employing adequate solvents. Solution deposition process exemplarily comprise spin coating, dip coating and jet printing. Liquid processing may optionally be carried out in an inert atmosphere (e.g., in a nitrogen atmosphere) and the solvent may optionally be completely or partially removed by means known in the state of the art.
Examples General synthesis scheme I
Rx Rix R" i Rxii Rx1 Rx' Rviii Rx Rxii \ / Rv" Br N N
N Br Rix N FF NaH Riv H CI +
El RVX ¨R2 dry toluene Rv 1 Rviii Rill Riv 120 C CI X CI
Rvl Rv"
R" ).<,R E3 E3 RI \N / Rvl N
H CI
E2 R" RI
RII Rxi Rill / \N
Ri Rxii N N tBuLi Ni j Riv Br Rix BBr3 THF Rv I
B R
NI,),,N Rviii d r '. 1 Rv I , dry -78 C Rvi N m / "i\ Rxii Rvi CI / X CI will RvIl R1 zi R2 Rviii RxI
Rix Rx General procedure for synthesis:
El (1.00 equivalent), E2 (1.00 equivalent) were dissolved in dry toluene under nitrogen atmosphere and cooled to 0 C in an ice-bath. NaH (1.05 equivalent) was added in small portions.
The reaction mixture was stirred at 0 C for 10 min. The ice-bath was then removed and the
25 reaction allowed to warm up to room temperature. A solution of E3 (0.50 equivalents) in dry toluene was added and the reaction mixture heated to reflux under nitrogen overnight. After cooling to room temperature, the reaction mixture was washed with water and brine, dried over MgSO4, filtered and the solvent removed. The crude product was purified by column chromatography.
Z1 (1.00 equivalent) was dissolved in dry THF and the solution was cooled to -78 C under nitrogen. A solution of tert-Butyllithium (tBuLi) (6.00 equivalents) was added dropwise and the reaction mixture was allowed to warm up to 0 C. After stirring for 30 minutes at 0 C, the reaction mixture was cooled again to -78 C.
A solution of boron tribromide (BBr3, 2.2 equivalents) in ether was added dropwise, the bath was removed and the reaction mixture was allowed to warm to room temperature (it).
Subsequently, the reaction mixture was heated at reflux overnight. After cooling to it, hexane and Et0Ac were added, the mixture was filtered through celite and the filtrate was evaporated on silica gel eluted with 98:2 hexane/CH2Cl2 to give P1.
Cyclic voltammetty Cyclic voltammograms are measured from solutions having concentration of 10-3 mol/L of the organic molecules in dichloromethane or a suitable solvent and a suitable supporting electrolyte (e.g. 0.1 mol/L of tetrabutylammonium hexafluorophosphate). The measurements are conducted at room temperature under nitrogen atmosphere with a three-electrode assembly (Working and counter electrodes: Pt wire, reference electrode: Pt wire) and calibrated using FeCp2/FeCp2+ as internal standard. The HOMO data was corrected using ferrocene as internal standard against SCE.
Density functional theory calculation Molecular structures are optimized employing the BP86 functional and the resolution of identity approach (RI). Excitation energies are calculated using the (BP86) optimized structures employing Time-Dependent DFT (TD-DFT) methods. Orbital and excited state energies are calculated with the B3LYP functional. Def2-SVP basis sets (and a m4-grid for numerical integration are used. The Turbomole program package is used for all calculations.
Photophysical measurements Sample pretreatment: Spin-coating Apparatus: Spin150, SPS euro.
Z1 (1.00 equivalent) was dissolved in dry THF and the solution was cooled to -78 C under nitrogen. A solution of tert-Butyllithium (tBuLi) (6.00 equivalents) was added dropwise and the reaction mixture was allowed to warm up to 0 C. After stirring for 30 minutes at 0 C, the reaction mixture was cooled again to -78 C.
A solution of boron tribromide (BBr3, 2.2 equivalents) in ether was added dropwise, the bath was removed and the reaction mixture was allowed to warm to room temperature (it).
Subsequently, the reaction mixture was heated at reflux overnight. After cooling to it, hexane and Et0Ac were added, the mixture was filtered through celite and the filtrate was evaporated on silica gel eluted with 98:2 hexane/CH2Cl2 to give P1.
Cyclic voltammetty Cyclic voltammograms are measured from solutions having concentration of 10-3 mol/L of the organic molecules in dichloromethane or a suitable solvent and a suitable supporting electrolyte (e.g. 0.1 mol/L of tetrabutylammonium hexafluorophosphate). The measurements are conducted at room temperature under nitrogen atmosphere with a three-electrode assembly (Working and counter electrodes: Pt wire, reference electrode: Pt wire) and calibrated using FeCp2/FeCp2+ as internal standard. The HOMO data was corrected using ferrocene as internal standard against SCE.
Density functional theory calculation Molecular structures are optimized employing the BP86 functional and the resolution of identity approach (RI). Excitation energies are calculated using the (BP86) optimized structures employing Time-Dependent DFT (TD-DFT) methods. Orbital and excited state energies are calculated with the B3LYP functional. Def2-SVP basis sets (and a m4-grid for numerical integration are used. The Turbomole program package is used for all calculations.
Photophysical measurements Sample pretreatment: Spin-coating Apparatus: Spin150, SPS euro.
26 The sample concentration is 10 mg/ml, dissolved in a suitable solvent.
Program: 1) 3 s at 400 U/min; 20 s at 1000 U/min at 1000 Upm/s. 3) 10 s at 4000 U/min at 1000 Upm/s. After coating, the films are tried at 70 C for 1 min.
Photoluminescence spectroscopy and TCSPC (Time-correlated single-photon counting) Steady-state emission spectroscopy is measured by a Horiba Scientific, Modell FluoroMax-4 equipped with a 150 W Xenon-Arc lamp, excitation- and emissions monochromators and a Hamamatsu R928 photomultiplier and a time-correlated single-photon counting option. Emissions and excitation spectra are corrected using standard correction fits.
Excited state lifetimes are determined employing the same system using the TCSPC method with FM-2013 equipment and a Horiba Yvon TCSPC hub.
Excitation sources:
NanoLED 370 (wavelength: 371 nm, puls duration: 1,1 ns) NanoLED 290 (wavelength: 294 nm, puls duration: <1 ns) SpectraLED 310 (wavelength: 314 nm) SpectraLED 355 (wavelength: 355 nm).
Data analysis (exponential fit) is done using the software suite DataStation and DAS6 analysis software. The fit is specified using the chi-squared-test.
Photoluminescence quantum yield measurements For photoluminescence quantum yield (PLQY) measurements an Absolute PL Quantum Yield Measurement C9920-03G system (Hamamatsu Photonics) is used. Quantum yields and CIE
coordinates are determined using the software U6039-05 version 3.6Ø
Emission maxima are given in nm, quantum yields cl) in % and CIE coordinates as x,y values.
PLQY is determined using the following protocol:
1) Quality assurance: Anthracene in ethanol (known concentration) is used as reference 2) Excitation wavelength: the absorption maximum of the organic molecule is determined and the molecule is excited using this wavelength 3) Measurement Quantum yields are measured, for sample, of solutions or films under nitrogen atmosphere. The yield is calculated using the equation:
PL ¨ nphoton, emited f -1c[Int es maTtPteled (A) intasabmsoPrbleed (AldA
cl) i &photon, absorbed= 1A ri,,,re ference i 1) r,tre ference i CI- l" emitted VI. absorbed e`,1
Program: 1) 3 s at 400 U/min; 20 s at 1000 U/min at 1000 Upm/s. 3) 10 s at 4000 U/min at 1000 Upm/s. After coating, the films are tried at 70 C for 1 min.
Photoluminescence spectroscopy and TCSPC (Time-correlated single-photon counting) Steady-state emission spectroscopy is measured by a Horiba Scientific, Modell FluoroMax-4 equipped with a 150 W Xenon-Arc lamp, excitation- and emissions monochromators and a Hamamatsu R928 photomultiplier and a time-correlated single-photon counting option. Emissions and excitation spectra are corrected using standard correction fits.
Excited state lifetimes are determined employing the same system using the TCSPC method with FM-2013 equipment and a Horiba Yvon TCSPC hub.
Excitation sources:
NanoLED 370 (wavelength: 371 nm, puls duration: 1,1 ns) NanoLED 290 (wavelength: 294 nm, puls duration: <1 ns) SpectraLED 310 (wavelength: 314 nm) SpectraLED 355 (wavelength: 355 nm).
Data analysis (exponential fit) is done using the software suite DataStation and DAS6 analysis software. The fit is specified using the chi-squared-test.
Photoluminescence quantum yield measurements For photoluminescence quantum yield (PLQY) measurements an Absolute PL Quantum Yield Measurement C9920-03G system (Hamamatsu Photonics) is used. Quantum yields and CIE
coordinates are determined using the software U6039-05 version 3.6Ø
Emission maxima are given in nm, quantum yields cl) in % and CIE coordinates as x,y values.
PLQY is determined using the following protocol:
1) Quality assurance: Anthracene in ethanol (known concentration) is used as reference 2) Excitation wavelength: the absorption maximum of the organic molecule is determined and the molecule is excited using this wavelength 3) Measurement Quantum yields are measured, for sample, of solutions or films under nitrogen atmosphere. The yield is calculated using the equation:
PL ¨ nphoton, emited f -1c[Int es maTtPteled (A) intasabmsoPrbleed (AldA
cl) i &photon, absorbed= 1A ri,,,re ference i 1) r,tre ference i CI- l" emitted VI. absorbed e`,1
27 wherein nphoton denotes the photon count and Int. the intensity.
Production and characterization of organic electroluminescence devices OLED devices comprising organic molecules according to the invention can be produced via vacuum-deposition methods. If a layer contains more than one compound, the weight-percentage of one or more compounds is given in %. The total weight-percentage values amount to 100 %, thus if a value is not given, the fraction of this compound equals to the difference between the given values and 100 %.
The not fully optimized OLEDs are characterized using standard methods and measuring electroluminescence spectra, the external quantum efficiency (in %) in dependency on the intensity, calculated using the light detected by the photodiode, and the current. The OLED device lifetime is extracted from the change of the luminance during operation at constant current density.
The LT50 value corresponds to the time, where the measured luminance decreased to 50 % of the initial luminance, analogously LT80 corresponds to the time point, at which the measured luminance decreased to 80 % of the initial luminance, LT 95 to the time point, at which the measured luminance decreased to 95 % of the initial luminance etc.
Accelerated lifetime measurements are performed (e.g. applying increased current densities).
Exemplarily LT80 values at 500 cd/m2 are determined using the following equation:
cd2 Lo LT80 (500 M2¨ = LT80(4) _______________________ cd2) \500 77¨ r2 wherein Lo denotes the initial luminance at the applied current density.
The values correspond to the average of several pixels (typically two to eight), the standard deviation between these pixels is given.
HPLC-MS:
HPLC-MS spectroscopy is performed on a HPLC by Agilent (1100 series) with MS-detector (Thermo LTQ XL). A reverse phase column 4,6mm x 150mm, particle size 5,0 pm from Waters (without pre-column) is used in the HPLC. The HPLC-MS measurements are performed at room temperature (it) with the solvents acetonitrile, water and THF in the following concentrations:
solvent A: H20 (90%) MeCN (10%) solvent B: H20 (10%) MeCN (90%) solvent C: THF (100%)
Production and characterization of organic electroluminescence devices OLED devices comprising organic molecules according to the invention can be produced via vacuum-deposition methods. If a layer contains more than one compound, the weight-percentage of one or more compounds is given in %. The total weight-percentage values amount to 100 %, thus if a value is not given, the fraction of this compound equals to the difference between the given values and 100 %.
The not fully optimized OLEDs are characterized using standard methods and measuring electroluminescence spectra, the external quantum efficiency (in %) in dependency on the intensity, calculated using the light detected by the photodiode, and the current. The OLED device lifetime is extracted from the change of the luminance during operation at constant current density.
The LT50 value corresponds to the time, where the measured luminance decreased to 50 % of the initial luminance, analogously LT80 corresponds to the time point, at which the measured luminance decreased to 80 % of the initial luminance, LT 95 to the time point, at which the measured luminance decreased to 95 % of the initial luminance etc.
Accelerated lifetime measurements are performed (e.g. applying increased current densities).
Exemplarily LT80 values at 500 cd/m2 are determined using the following equation:
cd2 Lo LT80 (500 M2¨ = LT80(4) _______________________ cd2) \500 77¨ r2 wherein Lo denotes the initial luminance at the applied current density.
The values correspond to the average of several pixels (typically two to eight), the standard deviation between these pixels is given.
HPLC-MS:
HPLC-MS spectroscopy is performed on a HPLC by Agilent (1100 series) with MS-detector (Thermo LTQ XL). A reverse phase column 4,6mm x 150mm, particle size 5,0 pm from Waters (without pre-column) is used in the HPLC. The HPLC-MS measurements are performed at room temperature (it) with the solvents acetonitrile, water and THF in the following concentrations:
solvent A: H20 (90%) MeCN (10%) solvent B: H20 (10%) MeCN (90%) solvent C: THF (100%)
28 From a solution with a concentration of 0.5mg/m1 an injection volume of 15 pL
is taken for the measurements. The following gradient is used:
Flow rate [ml/min] time [min] A[%] Brio] D[%]
3 16.01 40 50 10 Ionisation of the probe is performed by APCI (atmospheric pressure chemical ionization).
Example 1 B
¨N
0 N¨
Example 1 was synthesized according to the general procedure for synthesis, wherein 8-chloro-a-carboline and 1-bromo-2,6-difluorobenzene were used as reactants.
Additional Examples of organic molecules of the invention B B
N-N
B B
N
Si ,
is taken for the measurements. The following gradient is used:
Flow rate [ml/min] time [min] A[%] Brio] D[%]
3 16.01 40 50 10 Ionisation of the probe is performed by APCI (atmospheric pressure chemical ionization).
Example 1 B
¨N
0 N¨
Example 1 was synthesized according to the general procedure for synthesis, wherein 8-chloro-a-carboline and 1-bromo-2,6-difluorobenzene were used as reactants.
Additional Examples of organic molecules of the invention B B
N-N
B B
N
Si ,
29 B
/ \ N 0 -N N- -N I N-0 .
B la .
/\ N N /\ /\ B
N/4 /\
-N
* N- -N 1 N-. . * * *
* N N *
N N *
B
-N
N
N N
N N
B
-N N--N N-N
/ \ N 0 -N N- -N I N-0 .
B la .
/\ N N /\ /\ B
N/4 /\
-N
* N- -N 1 N-. . * * *
* N N *
N N *
B
-N
N
N N
N N
B
-N N--N N-N
30 N \ N B
N- , 0 0 -N I N N-= Ni-' N N
.
I, S.
B
/ \ N N / \ / \ N B
NI- i \
-NI I N-.
I
*
N N
S.
S.
B
N- N
\
B
I
Ni="" 1 N
N- , 0 0 -N I N N-= Ni-' N N
.
I, S.
B
/ \ N N / \ / \ N B
NI- i \
-NI I N-.
I
*
N N
S.
S.
B
N- N
\
B
I
Ni="" 1 N
Claims (11)
1. Organic molecule with of a structure of Formula l, wherein X is N or CR3;
R1, R2, R3, R I, R II, R III, R IV, R V, R VI, RVII, R VIII, R IX, R X, R XI, and R XII is independently from each other selected from the group consisting of:
hydrogen, deuterium, which is optionally substituted with one or more substituents R4;
C1-C40-alkoxyl, which is optionally substituted with one or more substituents R4;
C2-C40-alkenyl, which is optionally substituted with one or more substituents R4;
C2-C40-alkynyl, which is optionally substituted with one or more substituents R4;
C6-C60-aryl, which is optionally substituted with one or more substituents R4;
C3-C57-heteroaryl, which is optionally substituted with one or more substituents R4;
CN;
CF3;
N(R4)2;
OR4, and Si(R4)3;
R4 is at each occurrence independently from another selected from the group consisting of:
hydrogen, deuterium, OPh, CF3, CN, F, C1-C5-alkyl, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C1-C5-alkoxy, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C1-C5-thioalkoxy, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C2-C18-alkenyl, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C2-C18-alkynyl, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C6-C18-aryl, which is optionally substituted with one or more C1-C5-alkyl substituents;
C3-C17-heteroaryl, which is optionally substituted with one or more C1-C5-alkyl substituents;
N(C6-C18-aryl)2, N(C3-C17-heteroaryl)2; and N(C3-C17-heteroaryl)(C6-C18-aryl);
wherein substituent pairs selected from the group consisting of R IX and R VIII, R VIII and R VII, R VI and R V, and R V and R IV
optionally form a mono- or polycyclic, aliphatic, aromatic and/or benzo-fused ring system with each other.
R1, R2, R3, R I, R II, R III, R IV, R V, R VI, RVII, R VIII, R IX, R X, R XI, and R XII is independently from each other selected from the group consisting of:
hydrogen, deuterium, which is optionally substituted with one or more substituents R4;
C1-C40-alkoxyl, which is optionally substituted with one or more substituents R4;
C2-C40-alkenyl, which is optionally substituted with one or more substituents R4;
C2-C40-alkynyl, which is optionally substituted with one or more substituents R4;
C6-C60-aryl, which is optionally substituted with one or more substituents R4;
C3-C57-heteroaryl, which is optionally substituted with one or more substituents R4;
CN;
CF3;
N(R4)2;
OR4, and Si(R4)3;
R4 is at each occurrence independently from another selected from the group consisting of:
hydrogen, deuterium, OPh, CF3, CN, F, C1-C5-alkyl, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C1-C5-alkoxy, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C1-C5-thioalkoxy, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C2-C18-alkenyl, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C2-C18-alkynyl, wherein optionally one or more hydrogen atoms are independently from each other substituted by deuterium, CN, CF3, or F;
C6-C18-aryl, which is optionally substituted with one or more C1-C5-alkyl substituents;
C3-C17-heteroaryl, which is optionally substituted with one or more C1-C5-alkyl substituents;
N(C6-C18-aryl)2, N(C3-C17-heteroaryl)2; and N(C3-C17-heteroaryl)(C6-C18-aryl);
wherein substituent pairs selected from the group consisting of R IX and R VIII, R VIII and R VII, R VI and R V, and R V and R IV
optionally form a mono- or polycyclic, aliphatic, aromatic and/or benzo-fused ring system with each other.
2. Organic molecule according to claim 1, wherein R1, R2, R3, R I, R II, R
III, R IV, R V, R VI, R VII, R VIII, R IX, R X, R XI and R XII is independently from another selected from the group consisting of:
hydrogen, deuterium, halogen, Me, i Pr, t Bu, CN, CF3, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, pyridinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, pyrimidinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, triazinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, and N(Ph)2.
III, R IV, R V, R VI, R VII, R VIII, R IX, R X, R XI and R XII is independently from another selected from the group consisting of:
hydrogen, deuterium, halogen, Me, i Pr, t Bu, CN, CF3, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, pyridinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, pyrimidinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, triazinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, and N(Ph)2.
3. Organic molecule according to claim 1 or 2, wherein R3, R I, R III, R IV, R
VI, R VII, R X and R XII is independently from another selected from the group consisting of:
hydrogen, deuterium, halogen, Me, i Pr, t Bu, CN, CF3, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, pyridinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, pyrimidinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, and triazinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph;
R1, R2, R II, R V, R VIll and R Xl is independently from another selected from the group consisting of:
hydrogen, deuterium, Me, i Pr, t Bu, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, and N(Ph)2.
VI, R VII, R X and R XII is independently from another selected from the group consisting of:
hydrogen, deuterium, halogen, Me, i Pr, t Bu, CN, CF3, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, pyridinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, pyrimidinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, and triazinyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph;
R1, R2, R II, R V, R VIll and R Xl is independently from another selected from the group consisting of:
hydrogen, deuterium, Me, i Pr, t Bu, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, and Ph, carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph, and N(Ph)2.
4. Organic molecule according to claim 3, wherein R3, R I, R III, R IV, R VI
, R VII, R IX, R X and R XII is independently from another selected from the group consisting of hydrogen, deuterium, Me, i Pr, t Bu, CN, CF3, and Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph;
R1, R2, R II, R V, R VIII and R XI is independently from another selected from the group consisting of:
hydrogen, deuterium, Me, i Pr, t Bu, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, and Ph;
carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, t Bu, and Ph;
and N(Ph)2.
, R VII, R IX, R X and R XII is independently from another selected from the group consisting of hydrogen, deuterium, Me, i Pr, t Bu, CN, CF3, and Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, CN, CF3, and Ph;
R1, R2, R II, R V, R VIII and R XI is independently from another selected from the group consisting of:
hydrogen, deuterium, Me, i Pr, t Bu, Ph, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, i Pr, t Bu, and Ph;
carbazolyl, which is optionally substituted with one or more substituents independently from each other selected from the group consisting of Me, t Bu, and Ph;
and N(Ph)2.
5. Organic molecule according to claim 1, which consists of a structure of one of Formulas II to XXI:
6. Use of an organic molecule according to one or more of claims 1 to 5 as a luminescent emitter in an optoelectronic device.
7. Use according to claim 6, wherein the optoelectronic device is selected from the group consisting of:
.cndot. organic light-emitting diodes (OLEDS), .cndot. light-emitting electrochemical cells, .cndot. OLED-sensors, .cndot. organic diodes, .cndot. organic solar cells, .cndot. organic transistors, .cndot. organic field-effect transistors, .cndot. organic lasers, and .cndot. down-conversion elements.
.cndot. organic light-emitting diodes (OLEDS), .cndot. light-emitting electrochemical cells, .cndot. OLED-sensors, .cndot. organic diodes, .cndot. organic solar cells, .cndot. organic transistors, .cndot. organic field-effect transistors, .cndot. organic lasers, and .cndot. down-conversion elements.
8. Composition, comprising or consisting of:
(a) at least one organic molecule according to one or more of claims 1 to 5, in particular in the form of an emitter and/or a host, and (b) one or more emitter and/or host materials, which differ from the organic molecule of one or more of claims 1 to 5, and (c) optionally, one or more dyes and/or one or more solvents.
(a) at least one organic molecule according to one or more of claims 1 to 5, in particular in the form of an emitter and/or a host, and (b) one or more emitter and/or host materials, which differ from the organic molecule of one or more of claims 1 to 5, and (c) optionally, one or more dyes and/or one or more solvents.
9. Optoelectronic device, comprising an organic molecule according to one or more of claims 1 to and/or a composition according to claim 8, in particular in form of a device selected from the group consisting of organic light-emitting diode (OLED), light-emitting electrochemical cell, OLED-sensor, organic diode, organic solar cell, organic transistor, organic field-effect transistor, organic laser and down-conversion element.
10. Optoelectronic device according to claim 9, comprising or consisting of:
- a substrate, - an anode, and - a cathode, wherein the anode or the cathode are disposed on the substrate, and - at least one light-emitting layer, which is arranged between anode and cathode and which comprises the organic molecule according to claims 1 to 5 or a composition according to claim 8.
- a substrate, - an anode, and - a cathode, wherein the anode or the cathode are disposed on the substrate, and - at least one light-emitting layer, which is arranged between anode and cathode and which comprises the organic molecule according to claims 1 to 5 or a composition according to claim 8.
11. Process for producing an optoelectronic device, wherein an organic molecule according to any one of claims 1 to 5 or a composition according to claim 8 is used, in particular comprising the processing of the organic compound by a vacuum evaporation method or from a solution.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102017121106.3 | 2017-09-12 | ||
DE102017121106 | 2017-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3016789A1 true CA3016789A1 (en) | 2019-03-12 |
Family
ID=65721725
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3016789A Pending CA3016789A1 (en) | 2017-09-12 | 2018-09-07 | Organic molecules, in particular for use in optoelectronic devices |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA3016789A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111333671A (en) * | 2020-03-16 | 2020-06-26 | 清华大学 | A light-emitting material and its application and an organic electroluminescent device comprising the same |
WO2020217229A1 (en) | 2019-04-26 | 2020-10-29 | Idemitsu Kosan Co., Ltd. | Polycyclic compound and an organic electroluminescence device comprising the polycyclic compound or the composition |
WO2021020929A1 (en) * | 2019-08-01 | 2021-02-04 | 주식회사 엘지화학 | Compound and organic light emitting device comprising same |
WO2021122757A1 (en) * | 2019-12-20 | 2021-06-24 | Cynora Gmbh | Organic molecules for optoelectronic devices |
WO2021228114A1 (en) * | 2020-05-14 | 2021-11-18 | 季华实验室 | Boron-nitrogen compound, organic electroluminescence composition, and organic electroluminescence device comprising same |
CN114075229A (en) * | 2020-08-20 | 2022-02-22 | 江苏三月科技股份有限公司 | Boron-containing organic compound and application thereof in organic electroluminescent device |
WO2023104285A1 (en) * | 2021-12-07 | 2023-06-15 | Huawei Technologies Co., Ltd. | Boron doped polycyclic aromatic hydrocarbon emitting compound (b-pah) and method of synthesizing b-pah |
-
2018
- 2018-09-07 CA CA3016789A patent/CA3016789A1/en active Pending
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020217229A1 (en) | 2019-04-26 | 2020-10-29 | Idemitsu Kosan Co., Ltd. | Polycyclic compound and an organic electroluminescence device comprising the polycyclic compound or the composition |
CN114026101A (en) * | 2019-04-26 | 2022-02-08 | 出光兴产株式会社 | Polycyclic compound and organic electroluminescent device comprising polycyclic compound or composition |
WO2021020929A1 (en) * | 2019-08-01 | 2021-02-04 | 주식회사 엘지화학 | Compound and organic light emitting device comprising same |
CN113544136A (en) * | 2019-08-01 | 2021-10-22 | 株式会社Lg化学 | Compound and organic light emitting device including the same |
CN113544136B (en) * | 2019-08-01 | 2024-04-05 | 株式会社Lg化学 | Compound and organic light emitting device comprising the same |
WO2021122757A1 (en) * | 2019-12-20 | 2021-06-24 | Cynora Gmbh | Organic molecules for optoelectronic devices |
CN111333671A (en) * | 2020-03-16 | 2020-06-26 | 清华大学 | A light-emitting material and its application and an organic electroluminescent device comprising the same |
CN111333671B (en) * | 2020-03-16 | 2022-12-23 | 清华大学 | A kind of luminescent material and its application and organic electroluminescent device containing it |
WO2021228114A1 (en) * | 2020-05-14 | 2021-11-18 | 季华实验室 | Boron-nitrogen compound, organic electroluminescence composition, and organic electroluminescence device comprising same |
CN114075229A (en) * | 2020-08-20 | 2022-02-22 | 江苏三月科技股份有限公司 | Boron-containing organic compound and application thereof in organic electroluminescent device |
WO2023104285A1 (en) * | 2021-12-07 | 2023-06-15 | Huawei Technologies Co., Ltd. | Boron doped polycyclic aromatic hydrocarbon emitting compound (b-pah) and method of synthesizing b-pah |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3902811B1 (en) | Organic molecules for optoelectronic devices | |
EP3681972B1 (en) | Organic molecules, in particular for use in optoelectronic devices | |
CA3017010A1 (en) | Organic molecules, in particular for use in optoelectronic devices | |
CA3016789A1 (en) | Organic molecules, in particular for use in optoelectronic devices | |
EP3681973B1 (en) | Organic molecules, in particular for use in optoelectronic devices | |
EP3947399A1 (en) | Organic molecules for optoelectronic devices | |
WO2020035495A1 (en) | Organic molecules for optoelectronic devices | |
EP3765455A1 (en) | Organic molecules for optoelectronic devices | |
CA3017002A1 (en) | Organic molecules, in particular for use in optoelectronic devices | |
WO2018229053A1 (en) | Organic molecule, in particular for use in optoelectronic devices | |
EP4185655B1 (en) | Organic molecules for optoelectronic devices | |
WO2018189356A1 (en) | Organic molecules, in particular for use in optoelectronic devices | |
EP4139313A1 (en) | Organic molecules for optoelectronic devices | |
WO2021122757A1 (en) | Organic molecules for optoelectronic devices | |
EP4073076A1 (en) | Organic molecules for optoelectronic devices | |
EP3847167A1 (en) | Organic molecules for optoelectronic devices | |
EP3844160A1 (en) | Organic molecules for optoelectronic devices | |
EP3837254A1 (en) | Organic molecules for optoelectronic devices | |
EP3717474A1 (en) | Organic molecules for use in optoelectronic devices | |
CA3016778A1 (en) | Organic molecules, in particular for use in optoelectronic devices | |
WO2019115446A1 (en) | Organic molecules for use in optoelectronic devices | |
WO2019053046A1 (en) | Organic molecules, in particular for use in optoelectronic devices | |
EP3681975B1 (en) | Organic molecules, in particular for use in optoelectronic devices | |
EP4185581A1 (en) | Organic triazine containing molecules for use in optoelectronic devices | |
EP3844245A1 (en) | Organic molecules for optoelectronic devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20220929 |
|
EEER | Examination request |
Effective date: 20220929 |
|
EEER | Examination request |
Effective date: 20220929 |